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Abstract 
The aim of this project was to examine whether exposure to environmental 
and physiological stress conditions could affect some functional properties 
for the selection of probiotic microorganisms. The study was focused on two 
commercial strains of Bifidobacterium animalis ssp. lactis and two non-
commercial Bifidobacterium strains, namely B. breve NCTC 11815 and B. 
longum NCTC 11818. The effects of exposure to acid, bile, osmotic and 
oxidative stresses on their antimicrobial activity, biofilm formation capacity 
and antibiotic susceptibility profiles were assessed. The conditions to 
generate acid stress in the organisms were chosen as pH 3 for one hour, for 
both B. animalis ssp. lactis strains, and pH 4 for one hour, for B. breve and B. 
longum. Conditions for bile stress were 1% (w/v) bile for one hour, for both B. 
animalis ssp. lactis strains and B. breve, and 0.5% (w/v) bile for one hour, for 
B. longum. Osmotic stress conditions were 3% (w/v) NaCl for one hour, for 
both B. animalis ssp. lactis strains and B. breve, and 2% (w/v) NaCl for one 
hour, for B. longum. Oxidative stress was generated for all organisms by 
shaking at 200 rpm for two hours. The antimicrobial activities of all four 
bifidobacteria against pathogenic bacteria, namely Escherichia coli NCTC 
12900, Salmonella enterica ser. Typhimurium DT124 and S. enterica ser. 
Enteritidis PT4, were maintained after exposure to each stress, although 
there appeared to be lower inhibition after exposure to stress. This varied 
with strain and type of stress. The antibiotic susceptibility profiles of all four 
bifidobacteria for five antibiotics, namely tetracycline, erythromycin, ampicillin, 
chloramphenicol and vancomycin, were unchanged after exposure to each 
stress. The expression of tetracycline resistance gene tet(W) in one of the B. 
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animalis ssp. lactis strains, designated as strain C, was significantly higher 
(P ≤ 0.05) after exposure to acid, bile and osmotic stresses, although this did 
not translate to higher resistance of B. animalis ssp. lactis (C) to tetracycline. 
Effects of each stress on biofilm formation in the four bifidobacteria varied 
with the strain. In general, more positive effects of exposure to stress were 
observed in both B. animalis ssp. lactis strains, while more negative effects 
of exposure to stress were shown by B. breve and B. longum. The 
expression of exopolysaccharide-synthesis gene gtf01207 in B. animalis ssp. 
lactis (C) was significantly higher after exposure to osmotic stress, although it 
also appeared to be higher after exposure to acid and bile stresses. Studying 
the effects of exposure to stress on in vitro probiotic selection properties 
could give a better reflection of what applies in vivo, since microorganisms 
for probiotic use would be inevitably exposed to stresses. This could give a 
more accurate insight on the potential to provide health benefit. The results 
of this study may justify the commercial use of the B. animalis ssp. lactis 
strains. 
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1.1 Microbiology of the human gastrointestinal tract 
The human gastrointestinal tract (GIT) is the largest tube running through the 
body. It comprises the oral cavity (mouth), oesophagus, stomach, small 
intestine and large intestine. The main function of the GIT is for the digestion 
of food and absorption of nutrients (Shigwedha and Jia 2013). Its estimated 
surface area of 200 m2, in addition to being rich in molecules for use as 
nutrients by microbes, make it a major surface for microbial colonisation 
(Sekirov et al. 2010). 
The human GIT contains more than 1014 metabolically diverse and active 
microorganisms (Fig. 1.1), which constitute more than 70% of the total 
microbes in the human body (Sekirov et al. 2010). The population of gut 
microbiota alone is at least ten times more than the number of cells in the 
human body. The human “microbiome” plays a major role in the functions of 
the intestinal epithelium and consequently human health and disease 
(Bakhtiar et al. 2013).  Intestinal microbiota play important roles in digestion 
of food, development of the gut immune system, production of short-chain 
fatty acids and essential vitamins, and resistance to colonisation by 
pathogenic microbes (Behnsen et al. 2013). 
19 
 
 
 
Fig. 1.1 Microbiota of the human gastrointestinal tract (Adapted from Shigwedha 
and Jia 2013) 
 
 
 
 
 
Oesophagus 
Bacterial numbers: ~102 – 
104/ml contents 
e.g. streptococci, 
lactobacilli, Gram-negative 
bacilli 
Oral cavity (mouth) 
Bacterial numbers: 
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Stomach 
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~103/ml contents 
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Small intestine 
Bacterial numbers: ~104 
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bifidobacteria, clostridia, 
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fusobacteria, lactobacilli, 
enterobacteria, enterococci, 
eubacteria, methanogens, 
sulphate reducers, etc. 
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The intestine of a foetus is sterile until birth, at which point, microbial 
colonisation begins via inoculation with the mother’s vaginal and faecal flora, 
as well as the environment. Subsequent development of the intestinal 
microbiota is largely influenced by diet, i.e. breast feeding or formula feeding, 
as well as environmental factors. Upon weaning, the microbiota composition 
normalises and remains stable throughout most of adult life (O’Grady and 
Gibson 2005; Ray and Bhunia 2008).  
Different ecological niches are found in the GIT, with the composition and 
population varying with location. The oral cavity is made up of the mouth, 
nose and throat. The mouth is densely populated by microorganisms, 
including members of Prevotella, Porphyromonas, Desulfovibrio, Bacteroides, 
Fusobacterium, Eubacterium and Peptostreptococcus (O’Grady and Gibson 
2005). The stomach is almost sterile, with numbers <103 cfu/ml of gastric 
contents. This is due to its low pH, which is bactericidal. Microorganisms 
found in the stomach are transient rather than resident, and include acid-
tolerant lactobacilli, yeasts and Helicobacter pylori, which can survive the 
unfavourable and peristaltic conditions in the stomach (Chadwick et al. 2003). 
There is a progressive increase in the microbial numbers and species in the 
small intestine, from the duodenum (upper part) along to the jejunum and 
ileum (lower parts). The numbers in the duodenum are lower (~103 per gram) 
because of the secretion of bile, which inhibits bacterial growth, and the short 
transit time. In the ileum, the bacterial numbers start to grow, up to 107 per 
gram.  Species found include enterococci, enterobacteria, lactobacilli, 
bacteroides and clostridia. There is a rapid increase in population in the 
colon (large intestine), where microbial numbers can reach 1012 per gram of 
21 
 
content. The large intestine is favourable for microbial growth due to 
favourable pH, availability of nutrients, and slow transit time. The dominant 
bacteria in the large intestine are non-spore-forming anaerobes, including 
Bifidobacterium, Bacteroides, Eubacterium, Lactobacillus (O’Grady and 
Gibson 2005; Shigwedha and Jia 2013). 
 
1.2 Probiotics 
Probiotics, as defined by FAO/WHO (2002), are “live microorganisms which 
when administered in adequate amounts, confer a health benefit on the host”. 
Various species of bacteria and yeast have been used as probiotics (Table 
1.1). The most commonly used are strains of species of Lactobacillus and 
Bifidobacterium. Several health benefits have been associated with probiotic 
microorganisms and these benefits are strain-specific. Health claims should 
be supported by scientific evidence which can be based on results from 
clinical trials. Some of the potential claims are listed in Table 1.2. 
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Table 1.1 Examples of species which include probiotic strains 
Genus Species Example strains 
Bacillus coagulans, subtilis B. subtilis HU58 
Bifidobacterium adolescentis, animalis, bifidum, breve, infantis, lactis,  longum B. animalis ssp. lactis BB-12, B. animalis ssp. lactis HN019, 
B. breve Yakult, B. infantis UCC35624 
Enterococcus faecium E. faecium NCIMB10415 
Escherichia  coli  E. coli Nissle 
Lactobacillus acidophilus, casei, helveticus, johnsonii, paracasei, 
plantarum, reuteri, rhamnosus, salivarus 
Lb. acidophilus La-5, Lb. casei Shirota, Lb. johnsonii La-1, 
Lb. plantarum 299v, Lb. rhamnosus ATCC 53013 (LGG) 
Lactococcus lactis Lc. lactis ssp. lactis HV219 
Propionibacterium freudenrenchii, jensenii  P. freudenrenchii SI 41, P. jensenii 702 
Saccharomyces cerevisiae var. boulardii S. cerevisiae var. boulardii CNCM I-3799  
(Adapted from Vasiljevic and Shah 2008; Baker et al. 2009) 
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Table 1.2 Probiotics and associated potential health claims 
Health claims Probiotic organisms 
Diarrhoea treatment, cholesterol reduction, inhibition of colon cancer Lactobacillus acidophilus 
Treatment and prevention of diarrhoea, alleviation of atopic dermatitis Lactobacillus rhamnosus GG 
Immune system enhancement, modulation of intestinal microflora, vaccine adjuvant, Helicobacter pylori 
treatment 
Lactobacillus johnsonii La1 
Immune system enhancement, alleviation of atopic dermatitis, diarrhoea prevention and treatment 
(traveller’s diarrhoea, rotavirus diarrhoea) 
Bifidobacterium lactis Bb-12 
Treatment of viral diarrhoea, modulation of intestinal bacteria Bifidobacterium bifidum 
Treatment of rotavirus diarrhoea, acute diarrhoea Lactobacillus reuteri 
Modulation of intestinal microflora, inhibition of superficial bladder cancer Lactobacillus casei Shirota 
Modulation of intestinal microflora, increase of short-chain fatty acid production Lactobacillus plantarum 299v 
Diarrhoea prevention and treatment (traveller’s diarrhoea, Clostridium difficile-associated diarrhoea) Saccharomyces boulardii 
(Adapted from Saarela et al.2000; Dunne et al. 2001; Parvez et al. 2006)
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Dairy products such as yoghurt are the most common vehicles for delivering 
probiotics. Probiotic microorganisms should be present in these products in 
large enough numbers to compensate for losses during gastric passage. 
Daily intake has been suggested at 108 CFU/g (Granato et al. 2010a), which 
can be achieved by regular consumption of 400-500 g of product per week 
(Tamime et al. 1995). It has been recommended that minimum counts of 
around 106-107 CFU/g of product should be present by the time of 
consumption/expiry (Talwalkar and Kailasapathy 2004). Fermented and non-
fermented dairy products are commonly used because of the healthy image 
of such dairy products historically, as well as consumer familiarity with the 
live microbial content of these products (Charteris et al. 1998; Heller 2001; 
Ozer and Kirmaci 2010).  
Despite dairy products being the most common means of probiotic 
administration, there has been development in the area of non-dairy probiotic 
products, in a bid to increase consumer choice and to satisfy people with 
lactose intolerance or people who do not like dairy products for their higher 
fat content. Increasing vegetarianism and allergies to milk proteins are also 
contributing factors (Granato et al. 2010b; Ranadheera et al. 2010). Fruit 
juices, soy-based and cereal-based products have been found to be suitable 
as carriers of probiotics.  Lactobacillus plantarum 299v, Lactobacillus reuteri 
and Lactobacillus rhamnosus GG have been used to develop probiotic fruit 
juices/drinks under brand names like ProViva, Gefilus, Biola, Rela (Molin 
2001; Prado et al. 2008).  
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1.2.1 Probiotic selection criteria 
Microorganisms intended for use as probiotics would be required to meet 
certain criteria for selection. They would have to meet criteria based on 
safety characteristics, technological characteristics, functional characteristics 
and eventually they would be expected to provide the health benefits for 
which they are used. 
Safety criteria: Safety is one of the most important selection criteria for 
bacterial strains which are to be used in the food industry, including 
probiotics (Gueimonde et al. 2013). Microorganisms for probiotic use would 
preferably be of human origin and isolated from a healthy human 
gastrointestinal tract, be non-pathogenic and non-toxic (generally recognised 
as safe [GRAS]), and possess no transferrable antibiotic resistance genes 
(Saarela et al. 2000). Most bacteria for use in probiotic products have been 
isolated from humans to increase the likelihood of compatibility with the 
human gut and its microflora, and improve chances of survival (Rivera-
Espinoza and Gallardo-Navarro 2010). Non-pathogenicity implies that there 
is no risk of infection or other adverse side-effects from the consumption of 
probiotics (Reid 2006). Antibiotic resistance itself is not a safety issue, since 
microorganisms can possess inherent resistance. However, it becomes a 
safety issue where there is a risk of resistance transfer, i.e. transfer of 
genetic determinants to intestinal pathogens (Aureli et al.  2011). 
Technological criteria: Desired technological properties include good 
sensory properties, viability during propagation and processing, stability in 
the product and during storage, phage resistance and oxygen resistance 
(Ouwehand et al. 1999). Probiotic microorganisms chosen for incorporation 
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into food products should remain alive during the harsh conditions of food 
manufacture, and during storage of the food product for the shelf-life period 
(Sanchez et al. 2012). Many probiotic cultures are produced in dried form, 
which provides a longer shelf life. As such, the probiotic organisms would 
have to survive the extremes of osmotic and temperature conditions and the 
exposure to oxygen that occur during the drying process (Jancovic et al. 
2010). The conditions during the fermentation process, i.e. biomass 
production, such as composition of the fermentation medium, harvesting time, 
growth temperature and fermentation pH may also affect the survival of 
extreme temperature and stability during storage (Makinen et al. 2012). The 
addition of probiotics to food should also not compromise the sensory 
attributes of the food product (Sanchez et al. 2012).  
Functional criteria: Functional requirements, which are initially determined 
in vitro, include resistance to acid/gastric acid, resistance to bile, adhesion to 
the intestinal epithelium and ability to transiently colonise the gut, stimulation 
of the immune system, antagonistic activity against pathogens (production of 
antimicrobial compounds or competitive exclusion), anticarcinogenic and 
antimutagenic properties (Ouwehand et al. 1999; Saarela et al. 2000). Since 
probiotics are usually administered orally, it is crucial that they survive the 
acidic conditions of the stomach and the bile secreted into the small intestine 
(Chou and Weimer 1999). Therefore, candidate probiotics are screened for 
tolerance to acid and bile. Adhesion to intestinal surfaces is important for 
colonisation of the human gut, as it prevents the elimination of probiotics by 
peristalsis and provides competitive advantage over pathogens (Rivera-
Espinoza and Gallardo-Navarro 2010). Protective effects against pathogens 
27 
 
may also be exerted by direct antagonism, through the production of 
inhibitory compounds such as organic acids, bacteriocins and hydrogen 
peroxide, and by competitive exclusion, through the competition for nutrients 
(Baugher and Klaenhammer 2011). Probiotics may directly or indirectly 
influence the immune system, as well as bind mutagens to the cell surface 
and reduce sources of procarcinogens which lead to tumour development 
(Shah 2007). Functional properties, however, do not necessarily predict 
health benefits in humans, and are not requirements for a strain to be 
beneficial to health. Therefore, health benefits of candidate probiotic strains 
should always be demonstrated by well-designed human trials (Makinen et al. 
2012). 
 
1.2.2 Mechanisms of probiotic action 
Probiotic benefits may occur directly or indirectly by a number of 
mechanisms. These potential mechanisms revolve around modulation of the 
intestinal ecosystem, improved colonisation resistance and modulation of 
immune resistance (Fig. 1.2). 
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Fig. 1.2 Overview of mechanisms of activity attributed to probiotic microorganisms (adapted from Baker et al. 2009) 
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Modulation of intestinal ecosystem: The consumption of probiotics, and 
the transient colonisation which occurs, can influence the composition and 
activity of the natural gut microflora and help to maintain a beneficial balance 
by increasing the population of beneficial bacteria and decreasing the 
population of harmful microorganisms. This may be achieved by the 
production of organic acids or short chain fatty acids, which lower the gut pH, 
and the production of antimicrobial agents such as bacteriocins, thus making 
the gut more favourable to beneficial bacteria such as lactobacilli and 
bifidobacteria and consequently, less favourable to pathogenic 
microorganisms (Baker et al. 2009).   
Improved colonisation resistance: The growth and metabolism of probiotic 
microorganisms can alter the intestinal environment such that colonisation 
resistance is improved. This may result from adhesion to epithelial cells by 
probiotics, thus blocking the adhesion of pathogens (i.e. competitive 
exclusion), as well as the stimulation of mucin production, which enhances 
intestinal barrier function (Oelschlaeger 2010; Wohlgemuth et al. 2010).  
Modulation of immune resistance: Probiotics can stimulate mucosal 
immunity and modulate immune responses by their interaction with the gut-
associated lymphoid tissue (GALT). GALT is the largest lymphoid tissue in 
the human body and contains various cells of the immune system, which 
interact with intestinal microorganisms. Metabolites, cell wall components 
and DNA of probiotic microorganisms are recognised by host cells which are 
sensitive to them, e.g. toll-like receptors (TLRs), and the activation of these 
receptors lead to modulation of pro- and anti- inflammatory cytokine 
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expression, i.e. down-regulation of inflammatory and allergic responses 
(Baker et al. 2009; Wohlgemuth et al. 2010). 
 
1.3 Genus Bifidobacterium  
The genus Bifidobacterium consists of anaerobic, non-motile, 
heterofermentative Gram-positive rod-shaped bacteria which normally 
constitute part of the human and animal intestinal microflora (Sela et al. 
2010). The genus Bifidobacterium belongs to the Actinomycetaceae family. 
Bifidobacterium have a distinctly high G + C content (42% - 67%) (Klijn et al. 
2005) and were first isolated from breast-fed infant faeces by Tissier in 1899, 
who named it Bacillus bifidus, due to the characteristic Y shape. The genus 
contains 36 recognised species, which are listed in Table 1.3. Bifidobacteria 
have been isolated from various ecological habitats such as the human oral 
cavity, human and animal intestine/faeces, human vagina, insect gut and 
sewage (Sela et al. 2010). 
The optimum growth temperature is 37 – 41 °C, and no growth occurs below 
20 °C and above 46 °C. The optimum pH for growth to occur is 6.5 – 7.0 and 
no growth generally occurs below 4.5 and above 8.5. Fermentation of 
carbohydrates by bifidobacteria is via a fructose-6-phosphate 
phosphoketolase shunt (Fig. 1.3) differentiating bifidobacteria from 
lactobacilli, which use a glucose-6-phosphate shunt (Tamime et al. 1995; 
Klijn et al. 2005). 
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Table 1.3 Species of Bifidobacterium and their ecological origin 
 
 
 
Species 
Ecological origin 
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B. actinocoloniiforme    x    
B. adolescentis x       
B. angulatum x       
B. animalis 
ssp. animalis  
ssp. lactis 
     
 
x 
 
x 
 
B. asteroides    x    
B. bifidum x       
B. bohemicum    x    
B. bombi    x    
B. boum      x  
B. breve x       
B. catenulatum x       
B. choerinum      x  
B. coryneforme    x    
B. crudilactis     x   
B. cuniculi      x  
B. dentium  x      
B. gallicum x       
B. gallinarum      x  
B. indicum    x    
B. longum 
ssp. infantis 
ssp. longum  
ssp. suis 
 
x 
x 
 
     
 
 
x 
 
B. magnum      x  
B. merycicum      x  
B. minimum       x 
B. mongoliense     x   
B. pseudocatenulatum x       
B. pseudolongum 
ssp. globosum 
ssp. pseudolongum  
      
x 
x 
 
B. psychraerophilum      x  
B. pullorum      x  
B. ruminantium      x  
B. saeculare      x  
B. scardovii   x     
B. stercoris x       
B. subtile       x 
B. thermacidophilum 
ssp. porcinum 
         ssp. thermacidophilum  
      
x 
 
 
x 
B. thermophilum       x 
B. tsurumiense  x      
(Adapted from Lee and O’Sullivan 2010; Russell et al. 2011) 
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Fig. 1.3 Carbohydrate metabolism in bifidobacteria via fructose-6-phosphoketolase 
pathway (Adapted from Tamime et al. 1995) 
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Bifidobacteria are normal inhabitants of the human GIT, and they are 
reported to play certain metabolically important roles. These include 
production of conjugated linoleic acid (CLA), immunostimulation, production 
of short chain fatty acids (SCFAs), prebiotic utilisation and 
exopolysaccharide (EPS) production (Russell et al. 2011). 
Bifidobacteria predominate the microflora found in breast-fed infants, before 
weaning, in comparison to formula-fed infants. This has been associated with 
better health in breast-fed babies compared with formula-fed babies (Roger 
et al. 2010). Human breastmilk has been shown to contain Bifidobacterium-
stimulating or ‘bifidogenic’ factors, such as lactulose, N-acetyl-glucosamine-
containing saccharides and other human milk oligosaccharides (HMOs), 
which consist of short-chain trisaccharides, e.g. sialyllactose, and complex, 
high-molecular-weight glycans, e.g. N-acetyllactosamine polymers. These 
oligosaccharides are only partially digested in the small intestine, and are 
therefore able to reach the colon to selectively stimulate the development of 
bifidobacteria in the gut microbiota (Gonzalez et al. 2008; Lee and O’Sullivan 
2010). Genomic analyses of bifidobacteria found in the infant gut have 
revealed the possession of specialised genes that encode enzymes 
dedicated to the utilisation of HMOs (Ventura et al. 2012).  
The population of bifidobacteria decreases with age, from 90-95% of the total 
gut microbial population at infancy to 3-6% in adulthood, and this remains 
stable until elderly age, where further decline has been observed (Leahy et al. 
2005; Russell et al. 2011). Age-related changes in gut microflora have been 
linked to increased susceptibility to gastrointestinal disorders in the elderly 
(Baker et al. 2009). 
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1.3.1 Bifidobacteria as probiotics 
There has been a lot of interest in bifidobacteria because of their association 
with maintenance of gut health. This has led to their incorporation in probiotic 
dairy products and other food products (Jayamanne and Adams 2006). 
Probiotic properties have been found in strains of B. adolescentis, B. 
animalis, B. bifidum, B. breve and B. longum (Russell et al. 2011).  
Various potential health benefits have been associated to strains of 
bifidobacteria, based on animal and human studies. Some of these studies 
have been criticised for poor design and weak conclusions (Lee and 
O’Sullivan 2010). Potential probiotic health benefits associated to 
bifidobacteria include prevention of diarrhoea (Saavedra et al. 1994; 
Chouraqui et al. 2004), alleviation of lactose intolerance (Jiang et al. 1996; 
He et al. 2008), cancer prevention (Rowland et al. 1998; Le Leu et al. 2010), 
cholesterol reduction (Xiao et al. 2003; Ataie-Jafari et al. 2009), modulation 
of the immune system (Arunachalam et al. 2000; Lee et al. 2004) and 
establishment of healthy microflora in premature infants (Li et al. 2004; Wang 
et al. 2007). 
Bifidobacteria have a long history of safe use as probiotics, with low risk of 
causing infection (Russell et al. 2011). The five species of Bifidobacterium 
with Qualified Presumption of Safety (QPS) status, i.e. B. adolescentis, B. 
animalis, B. bifidum, B. breve and B. longum (EFSA 2012), which contain 
probiotic strains, have not been linked to infections in healthy individuals 
(Gueimonde et al. 2013).   
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Some probiotic strains of bifidobacteria have been demonstrated to show no 
mucin-degrading activity, as well as no translocation ability in a normal host 
(Abe et al. 2010). Mucin degradation and translocation are important for 
safety because bacterial translocation from probiotic consumption could 
result in infections such as bacteraemia, sepsis and endocarditis 
(bloodstream infections). Mucin on the intestinal wall is important to prevent 
bacterial translocation. Translocation starts with the invasion of bacteria 
through the intestinal wall, therefore mucin degradation activity is used as an 
index of safety (Ishibashi and Yamazaki 2001; Abe et al. 2010).   
Furthermore, the transferability of antibiotic resistance genes from 
bifidobacteria to other enteric bacteria has not been demonstrated 
(Gueimonde et al. 2013). 
Although the bifidobacteria used as probiotics are known to be safe, correct 
identification and labelling is crucial to ensure safety, because some rare 
cases of bifidobacteria causing infection have been reported, and it is not 
uncommon to have the species of Bifidobacterium used not indicated on the 
label, or the organism simply referred to as ‘bifidus’ (O’Brien et al. 1999). 
Bifidobacterium dentium has been implicated as an opportunistic pathogen 
associated with the development of dental caries (Ventura et al. 2009). 
Similarly, B. scardovii has been associated with infection in an 
immunocompromised elderly patient (Barberis et al. 2012). However, the 
administration of probiotic bifidobacteria has also been linked to sepsis, but 
involving an immunocompromised patient as well (Ohishi et al. 2010). 
Therefore, care may have to be taken when administering probiotics to 
vulnerable patients.     
36 
 
Generally, bifidobacteria grow slowly in milk and also show poor survival in 
fermented milk products (Goderska and Stanton 2010). They are therefore 
usually not used for fermentation on their own, but rather added as adjunct 
cultures to traditional yoghurt starter cultures, i.e. Streptococcus 
thermophilus and Lactobacillus delbrueckii ssp. bulgaricus, either at the start 
of the fermentation process, or after fermentation has finished (Maus and 
Ingham 2003). Furthermore, the growth of bifidobacteria in milk may affect 
the sensory properties of the final product, due to the production of acetic 
acid (Margolles and Sanchez 2012).  
Among the probiotic bifidobacteria known, the most commonly used 
bifidobacteria commercially appear to be strains of B. animalis ssp. lactis. 
This may be due to better technological properties in comparison to the other 
bifidobacteria, which are of human intestinal origin (Raeisi et al. 2013). B. 
animalis ssp. lactis has been shown to have higher acid tolerance, as well as 
better tolerance to oxygen and heat and survival during storage (Simpson et 
al. 2005; Jayamanne and Adams 2006; Jayamanne and Adams 2009; Ruiz 
et al. 2012). 
 
1.4 Microbial stress 
For bacteria, there are conditions which can be considered as optimum, 
where growth and multiplication is facilitated. Conditions outside the optimum 
range, with the potential to decrease bacterial growth, can be considered as 
stressful. Therefore, environmental stress can be defined as external factors 
which have adverse impacts on the physiological welfare of bacterial cells, 
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resulting in reduced growth rate or, in extremes, resulting in inhibition (i.e. 
bacteriostatic) and/or death of individual cells or populations of cells (i.e. 
bacteriocidal) (McMahon et al. 2007b).  
Examples of stresses include nutrient depletion (starvation), presence of 
toxic or inhibitory compounds, extremes of temperature, pH, osmotic 
pressure. Such conditions can induce the expression of specific genes in 
response and may also result in sublethally injured microorganisms (Wesche 
et al. 2009). 
Stress can be classified on the basis of severity into suboptimal, sublethal 
and lethal (Ray and Bhunia 2008). Suboptimal conditions are those still 
within the growth range, but where growth is reduced. Bacterial cells show 
stress adaptation under suboptimal conditions. Under sublethal conditions, 
growth is less likely to occur and bacterial cells can suffer sublethal injury, 
which is reversible. Lethal conditions are those severe enough to cause cell 
death or irreversible injury.   
Various types of damage can be caused by stressful conditions. When cells 
are exposed to stress, they are either unaffected, sublethally injured, or lose 
viability completely. Sublethal injury may cause a change in physiology. 
Stress may cause damage to the cell wall and cytoplasmic membrane, 
damage to ribosomes and RNA or damage to DNA. This injury may be 
manifested as loss of virulence, sensitivity to selective agents (in media), 
sensitivity to secondary stress, sensitivity to oxidative stress (reactive oxygen 
species), or extended lag periods, which allow for repair of damage 
(Stephens and Mackey 2003). These are summarized in Table 1.4. 
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Table 1.4 Sublethal injury in bacterial cells 
Manifestation of injury Possible cause of injury 
Altered metabolism Enzyme inactivation 
Membrane damage, leading to changes in 
enzyme/substrate accessibility 
Extended lag Need to resynthesise damaged membranes, 
nucleic acids, ribosomes, etc. 
Sensitivity to oxidative stress Inactivation of catalase, superoxide 
dismutase 
Increased metabolic production of H2O2 or 
O2- 
Loss of cofactors for DNA repair enzymes 
Loss of intracellular reductants 
Sensitivity to acid, alkali, osmotic stress Cytoplasmic membrane damage 
Sensitivity to bile salts, hydrophobic 
antibiotics, lytic enzymes 
Damage to Gram-negative outer membrane 
or Gram-positive surface protein layer 
Increased frequency of mutation Damage to DNA 
(Adapted from Mackey 2000)  
 
Understanding how microorganisms are affected by stress is important, 
especially in food processing, and prevention and control of food-borne 
pathogens. It is particularly necessary to understand the various strategies 
employed by these microorganisms to survive stress. 
 
1.5 Stress and probiotic microorganisms 
Microorganisms for probiotic use are faced with stressful conditions at 
various stages from processing to storage and gut transit, which could affect 
viability (Lacroix and Yildirim 2007). Stresses could affect the physiological 
activity of the probiotic microorganisms, and as a consequence, affect their 
functionality (Kheadr et al. 2007). Stresses faced by probiotic 
microorganisms may be classified as technological, which occur during 
preparation of probiotic formulations in large-scale and during storage in the 
products, or as gastrointestinal, which occur during transit through the 
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human GIT (Ruiz et al. 2011). Stress conditions probiotic microorganisms 
may be exposed to are summarised in Table 1.5. 
 
Table 1.5 Stress conditions faced by probiotic microorganisms 
Type Stage Stress vector 
Technological 
 
Fermentation and 
processing 
 Composition of growth medium 
 Presence of organic acids during cultivation 
 High osmotic pressure and low water activity during 
cell dehydration 
 Extremes of temperature during spray drying and 
freeze drying 
 Oxygen exposure during fermentation, drying and 
storage 
Storage in probiotic-
containing product 
(carrier) 
 Increased acidity (pH < 5) 
 Presence of oxygen 
 Strain antagonism 
 Nutrient depletion 
 Presence of antimicrobial compounds  
 Storage temperature 
Gastrointestinal Mouth Oxygen, enzymes 
Stomach Acid, enzymes 
Small intestine Bile, enzymes  
Colon Nutrient starvation, microbiota 
(Adapted from Lacroix and Yildirim 2007; Vasiljevic and Shah 2008; Mills et 
al. 2011; Ruiz et al. 2011) 
 
Probiotic microorganisms should be able to survive these stress conditions. 
Lactic acid bacteria (LAB) and bifidobacteria have been shown to possess 
defence mechanisms to aid their survival during exposure to various stress 
conditions (Corcoran et al. 2008). Numerous studies have been carried out 
to understand these mechanisms in various LAB and bifidobacteria. Such 
mechanisms include proteases to degrade damaged proteins, chaperone 
proteins, which facilitate the folding of misfolded proteins, proton pumps, 
transporters and decarboxylases to combat decreases in intracellular pH, 
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catalases and superoxide dismutase to combat reactive oxygen species, and 
transport systems to maintain correct osmolarity (Mills et al. 2011). Some of 
these mechanisms are summarised in Table 1.6 and further illustrated in 
Figure 1.4. 
 
1.5.1 Acid stress response 
Acid stress occurs during passage through the stomach (De Dea Lindner et 
al. 2007). The stomach has a low pH due to the presence of hydrochloric 
acid in gastric juice, and is thus almost sterile (Chadwick et al. 2003). In 
addition, the presence or production of lactic and other organic acids in 
fermented dairy products used for probiotic delivery, owing to fermentation of 
lactose by lactic acid bacteria, reduces the pH of the milk, thereby creating 
acid stress (Sanchez et al.  2007a). 
Low environmental pH has negative implications for bacterial cells, and could 
cause severe damage.  Acid exposure causes a reduction in intracellular pH 
due to intracellular accumulation of protons, and also affects transmembrane 
pH. This alters the proton motive force (PMF) which is necessary for 
transport processes across the membrane. Acid stress could cause damage 
to the cell membrane, DNA and proteins, and is one of the most crucial 
stresses, as well as accumulation of oxidative intermediates. Thus, acid 
resistance is one of the criteria for probiotic selection (Corcoran et al. 2008). 
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Table 1.6 Strategies of stress response in some probiotic Bifidobacterium 
spp. 
Stress 
source 
Strategy of response Molecular mechanisms/players 
Heat  Proper protein folding Molecular chaperones: GroEL, GroES, GrpE, DnaJ, 
DnaK, ClpB, Hsp20 
Degradation of misfolded proteins Proteases: ClpC, ClpP 
Regulatory network Transcriptional regulators: HrcA, HspR, CglR 
Acid  Proton extrusion F1F0-ATPase 
Cytoplasm buffering/ammonia 
production 
Branched-chain amino acid production 
Glutamine synthetase 
Unknown CysD, MetE 
Bile Bile salt/acid detoxification Multidrug transporters and bile efflux pumps (BetA, 
Ctr) 
Bile salt deconjugation Bile salt hydrolase 
Alteration of cell surface Production of extracellular exopolysaccharides 
Changes in fatty acid composition 
Changes in surface-associated proteins: enolase, 
oligopeptide binding proteins 
Changes in energetic metabolism Increase in ATP synthesis 
Changes in the ratios of final glycolytic products 
Modification of redox status Methionine synthetase, Peroxidase 
Proper protein folding Molecular chaperones: ClpB, HtrA, GrpE, GroES,  
Degradation of misfolded proteins Proteases: ClpC 
Oxygen ROS-scavenging enzymes NADH oxidase, NADH peroxidase, Mn-superoxide 
dismutase 
DNA/RNA-protective proteins Dpr (DNA-binding ferritin-like protein) 
NrdA (ribonucleotide reductase) 
MutT1 (NTP phosphohydrolases) 
Oxygen stress-protective proteins AhpC (alkyl hydroperoxide reductase C22) 
PNDR (Pyridine nucleotide-disulfide reductase) 
Osmotic Proper protein folding Molecular chaperones: GroEL, GroES, Hsp20, 
DnaK, GrpE, DnaJ1, DnaJ2 
Transport systems ATP-binding cassettes (ABC): OpuA, BusA 
Ion motive-force driven transporters: BetP, ProP 
Cold Small heat shock proteins Hsp18.5, Hsp19.3, Hsp18.55  
Cold shock proteins CspA, CspL,  
Cold induced proteins ClpP (Clp ATPase family, members act as 
chaperones and regulators of proteolysis) 
Pyruvate kinase 
Glycoprotein endopeptidase 
(Adapted from Corcoran et al. 2008; Mills et al. 2011; Ruiz et al. 2011) 
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Fig. 1.4 Molecular mechanisms involved in the response of bifodobacteria to different 
stresses. A) Bile is detoxified from the cytoplasm by the activity of bile efflux 
pumps and/or multidrug transporters. Conjugated bile acids are 
deconjugated by the bile salt hydrolase (BSH), although the relationship of 
this enzyme with the resistance to bile is unclear. B) Both bile and heat 
shock induce protein aggregation and misfolding, which is counteracted by 
the action of chaperones and proteases. C) The F1F0-ATPase is used by 
bifidobacteria for counteracting the cytoplasm acidification that occurs in 
acidic environments. In addition, production of branched-chain amino acids is 
coupled with glutamine deamination, rendering ammonia that acts as a 
cytoplasmic buffer (Ruiz et al. 2011). 
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Lactobacilli and bifidobacteria have been demonstrated to possess an acid 
tolerance response (ATR), which enables their survival under acidic 
conditions, by maintaining their cytoplasmic pH near neutral (De Dea Lindner 
et al. 2007). The main mechanisms are via proton translocation (extrusion) 
by the F1F0-ATPase, which is a multi-subunit enzyme whose activity in 
anaerobic bacteria is enhanced at low pH; and via alkalinization of the 
cytoplasm by ammonia formation, which occurs from glutamine deamination. 
The ammonia formed captures protons, thus acting as a cytoplasmic buffer 
at low pH (Sanchez et al. 2010b; Ruiz et al. 2011).   
 
1.5.2 Bile stress response  
In the small intestine, the presence of bile salts is inhibitory to microbial 
growth, and thus, low numbers of microorganisms are found (Chadwick et al. 
2003). Bile salts are biological detergents and are found in bile, which is 
secreted into the small intestine for the emulsification and absorption of fats. 
The antimicrobial action of bile is displayed by inducing membrane damage, 
protein misfolding, and causing DNA injury by oxidative shock and low 
intracellular pH (Sanchez et al. 2007b; Mills et al. 2011). Resistance to the 
lethal action of bile salts is thus crucial for probiotic microorganisms.   
There are various bile tolerance mechanisms in response to the various 
effects of bile on cells. Unconjugated bile acids such as cholic acid can 
passively accumulate in cells by freely crossing the lipid bilayer. This leads to 
reduction in intracellular pH, causing leakage of ions and cellular 
components, thus leading to cell death. To combat this, bile tolerant cells 
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have efflux pumps for extrusion of bile acids. In response to the higher 
energy requirements under stress, bile tolerant cells are able to modify their 
sugar metabolism (in order to produce more energy) and their redox status in 
the presence of bile (Sanchez et al. 2010b).  
Oxidative damage caused by bile exposure (resulting from production of 
oxygen free radicals) can be dealt with by the induction of enzymes involved 
in the SOS response, i.e. a stress response to DNA damage, such as a 
thioredoxin-dependent thiol peroxidase and a Dps protein (DNA-binding 
protein from starved cells). Another mechanism to deal with oxidative 
damage is by reduced production of enzymes involved in methionine 
biosynthesis (the methionine sulphur group is susceptible to oxidation). The 
effect of bile on protein conformation can be combated by the overproduction 
of chaperones and proteases to conduct proper folding of proteins and 
promote quicker recycling of misfolded proteins (Ruiz et al. 2011) 
In response to the effects of bile on the cell surface, which is the first target 
of bile action, increased production of exopolysaccharide (EPS) can confer 
protection against bile. Also, changes in the lipid composition of the cell 
membrane are induced in the presence of bile, which can reduce the bile salt 
diffusion rate into the cytoplasm, thus enhancing bile tolerance.  Also, a 
relationship has been observed between bile adaptation and increase in 
production of bile salt hydrolase (BSH) enzyme, which is responsible for bile 
salt deconjugation, though its role is not clear (Sanchez et al. 2010b; Ruiz et 
al. 2011).  
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1.5.3 Heat stress response 
Probiotics are commonly grown to high numbers before undergoing drying 
processes to produce powders which can be added to probiotic products. 
The bacteria are exposed to high temperatures during spray-drying, up to 
200 °C, for a short time, which can disrupt the integrity of viable bacterial 
cells (De Dea Lindner et al. 2007; Mills et al. 2011). Lactobacilli and 
bifidobacteria are sensitive to temperatures above 50 °C. Heat stress affects 
microbial activity and growth by affecting the bacterial membrane, which 
consists of fatty acids susceptible to heat damage. Subsequent aggregation 
of proteins and damage to ribosomes and RNA also occurs, as a result of 
protein denaturation from the destabilisation of non-covalent interactions at 
high temperatures (Corcoran et al. 2008; Champomier-Verges et al. 2010). 
Heat shock has been widely studied in lactobacilli and bifidobacteria. They 
can utilise several heat shock proteins, including chaperones such as GroES, 
GroEL, DnaK and proteases such as HtrA (high temperature requirement), 
ClpC, ClpP (caseinolytic protease) to combat heat stress. These are induced 
by increasing temperatures. Small heat shock proteins (sHsps), which are 
ATP-independent chaperones, are also associated with enhanced bacterial 
survival during exposure to heat stress. They are necessary for growth, 
stability of DNA and RNA and preventing the formation of inclusion bodies, 
but not involved in protein re-folding (Mills et al. 2011; Ruiz et al. 2011). 
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1.5.4 Oxidative stress response 
Lactobacilli are microaerophilic and bifidobacteria are obligate anaerobes, 
though some species exhibit tolerance to microaerophilic levels, e.g. 
Bifidobacterium psychraerophilum. Probiotic bacteria are exposed to 
oxidative stress at different stages in their production, as well as in the GIT 
(Corcoran et al. 2008). Probiotic microorganisms in yoghurts are exposed to 
dissolved oxygen as a result of the mixing processes in manufacture which 
incorporate oxygen in the product, as well as diffusion of oxygen through the 
packaging materials (Talwalkar et al. 2004). Exposure to oxygen has been 
suggested as one of the reasons for loss in viability of probiotics. This is due 
to the formation of reactive oxygen species (ROS) such as superoxide, 
hydroxyl and hydrogen peroxide (H2O2) from incomplete reduction of oxygen, 
which can cause damage by reacting with proteins, lipids and DNA 
(Corcoran et al. 2008; Li et al. 2010). Tolerance to oxygen is therefore a 
desirable characteristic for probiotic microorganisms.  
Anaerobes lack the enzymes catalase and superoxide dismutase (SOD) 
which can decompose and detoxify ROS (Li et al. 2010). Enzymes such as 
NADH oxidase and NADH peroxidase are required by anaerobic lactobacilli 
and bifidobacteria to scavenge environmental oxygen and H2O2 respectively. 
Higher levels of these enzymes are found in the more aerotolerant 
organisms, thus protecting against oxygen toxicity (Talwalkar and 
Kailasapathy 2003). Damage to proteins is combated by the induction of 
protective proteins like AhpC and PNDR, and DNA and RNA are protected 
from damage by induction of proteins like Dpr, NrdA, MutT1 and enolase, in 
the presence of oxygen (Xiao et al. 2011). Dpr (dps-like peroxide resistance) 
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induction leads to production of a feritin-like iron scavenger upon exposure to 
H2O2, which prevents the overabundance of free iron that leads to oxidative 
damage (Wesche et al. 2009, Yamamoto et al. 2011). 
 
1.5.5 Cold stress response  
Probiotics in dairy products are exposed to low temperature prior to 
consumption, during production and storage (Corcoran et al. 2008). It is 
known that numbers of probiotic microorganisms decline with time during 
cold storage, and low temperatures are considered as a reason for loss in 
viability (Maus and Ingham 2003). Low (freezing) temperatures also cause 
membrane damage and affect replication, transcription and translation 
(Champomier-Verges et al. 2010). Cryotolerance (i.e. cold tolerance) is thus 
a desirable feature in probiotic bacteria.  
The induction of chaperones and proteases such as ATP-dependent ClpP is 
important for enhancing cold tolerance. Also, cold shock proteins e.g. CspL 
are over-expressed after cold shock and appear to stabilize mRNA. Some 
small heat shock proteins are also expressed following cold shock. The 
protease functions by proteolysis of misfolded and damaged proteins 
generated by cold shock (Champomier-Verges et al. 2010). The induction of 
ATP-dependent ClpP is the main adaptive response to cold in lactobacilli. 
Also, alterations (increase) in the unsaturated fatty acid composition of 
membranes occur during cold adaptation, which maintains membrane fluidity 
during cold stress, thus enhancing cryotolerance (Wang et al. 2005; 
Corcoran et al. 2008). 
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1.5.6 Osmotic stress response 
Osmotic stress may occur during spray drying and freeze drying, and may 
also occur due to the presence of salt (NaCl or KCl). In the gut, osmotic 
stress in bacteria results from fluctuations in diet (De Dea Lindner et al. 
2007). Osmotic stress can occur from shifts in external osmolarity, which 
leads to movement of water out of the cell, excessive movement of which, 
can lead to cell damage or death (Wesche et al. 2009). Cells need to adjust 
their intracellular osmolyte concentration, in order to retain turgour during 
osmotic upshift (De Angelis and Gobbetti 2004; Corcoran et al. 2008). 
Lactobacilli and bifidobacteria are unable to accumulate sufficiently high 
concentrations of Na+ or K+ to maintain turgour, and they synthesise very low 
levels of compatible solutes which serve as osmotic balancers. As such, 
transport systems are necessary to take up solutes and enhance osmotic 
tolerance (Corcoran et al. 2008; Mills et al. 2011). Molecular chaperones are 
also produced under osmotic shock to promote proper protein folding. GroEL 
and DnaK, which are heat shock proteins, are induced under osmotic shock, 
thus indicating some overlaps between heat and osmotic stress responses 
(Prasad et al. 2003). 
 
1.6 Effects of stress on probiotic functionality 
There have been several studies about the behaviour and responses of 
probiotic microorganisms to the various stresses they can be exposed to. 
The studies on lactic acid bacteria and bifidobacteria in relation to stress 
have been mainly in the context of monitoring their survival and viability, and 
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understanding the genes and proteins involved in their stress response, and 
how these aid their survival of sublethal stress, and their viability (Schmidt 
and Zink 2000; De Angelis and Gobbetti 2004). Some of these have been 
highlighted in the previous section. 
Similar studies have been done on other organisms, especially pathogens, 
e.g. Salmonella (Alvarez-Odonez et al. 2011), Bacillus cereus (Mols and 
Abee 2011), Listeria (Moorhead and Dykes 2004), Campylobacter (Birk et al. 
2012), on how they respond to environmental and physiological stress, with 
focus on growth/survival and pathogenicity.  These have been aimed at 
developing strategies for preventing and controlling such pathogens, such as 
in food processing and preservation, to ensure food safety. 
There have been no known studies which have examined if and/or how 
exposure to stress can affect the functionality of viable bacteria for potential 
probiotic use. Research has been done on pathogenic microorganisms, 
which suggest that exposure to stressful conditions might aid their virulence. 
For instance, a study by Begley et al. (2009) showed that exposure to bile 
influences biofilm formation in Listeria monocytogenes, which may contribute 
to its survival and virulence in the human gastrointestinal tract. Links have 
been found between the induction of stress-tolerance responses and 
increased virulence in pathogenic Escherichia coli, Listeria monocytogenes 
and Salmonella typhimurium, in which the synthesis of virulence genes is 
regulated by the exposure to hostile conditions (Archer 1996; Gahan and Hill 
1999). 
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To draw a parallel with probiotic microorganisms, it could be hypothesised 
that exposure to stress may aid probiotic microorganisms in their functionality, 
or otherwise impede them. Studies have been conducted on the influences 
on manufacturing conditions on some in vitro properties of probiotic 
lactobacilli. Grzeskowiak et al. (2011) reported differences in the in vitro 
properties of Lactobacillus rhamnosus GG isolates from different sources 
(probiotic products). It was suggested that different manufacturing processes 
may have an impact on strain properties. Similar suggestions were made by 
Nivoliez et al. (2012) in their comparative study of Lactobacillus rhamnosus 
Lcr35 and four of its commercial formulations. These variations between 
isolates may be due to genetic rearrangements within the genome of the 
strain as a result of differing manufacturing conditions, thus impacting on 
functionality (Sybesma et al. 2013). However, none of these studies have 
explicitly linked any of these differences with specific stress conditions.  
Resistance of probiotic Lactobacillus strains to low pH and bile has been 
demonstrated to be influenced by the type carbohydrate used as carbon 
source in the medium the lactobacilli were grown on (Hernandez-Hernandez 
et al. 2012; Nazzaro et al. 2012). In addition, Fayol-Messaoudi et al. (2005) 
showed that the temperature at which Lb. rhamnosus GG was grown had an 
influence on its anti-pathogen activity. A significant reduction in the killing 
activity against Salmonella enterica ser. Typhimurium was observed when Lb. 
rhamnosus GG was grown at 32 °C, compared to when grown at 37 °C. This 
report may indicate an effect of stress on functional properties of probiotics. 
It is important to study the functionality of probiotics exposed to stress 
conditions because they are usually available within food products, 
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consequently implying that they are inevitably faced with stressful conditions, 
not to mention the stress they go through in the human gastrointestinal tract, 
upon consumption. Any significant effects of stress conditions on the 
functional properties could have implications on how probiotics are produced 
and delivered. Therefore, research is needed to provide knowledge on the 
specific effects of individual stresses on different aspects of probiotic 
functionality. 
 
1.7 Aims and objectives 
Potential probiotic microorganisms are usually screened in vitro for acid and 
bile tolerance, in order to predict in vivo survival capacity when encountering 
acid and bile stress. However, the need to consider other stresses, including 
osmotic and oxidative stress, when selecting probiotic strains, has been 
highlighted (Lebeer et al. 2008). Acid stress occurs in the stomach, but also 
during fermentation, due to the production and accumulation of organic acids 
such as lactic acid. Bile stress occurs in the small intestine, due to the 
secretion of bile salts. Oxidative stress occurs in the mouth, but also during 
production and storage, because of the presence of oxygen. Osmotic stress 
occurs due to changes in the bacterial environment, and also due to the 
presence of salt ions, which result in movement of water in or out of the cell. 
It is expected that probiotics are able to confer health benefits despite 
exposure to stressful conditions. Whilst reduction in numbers may occur 
during gut transit, sufficient numbers should still be able to survive. Injury 
may occur among the surviving cells, but they should be able to recover and 
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retain their health-promoting properties. Probiotic microorganisms should be 
able to form biofilms in the gut and produce antagonistic (antimicrobial) 
compounds in order to out-compete undesirable bacteria and colonise the 
gut. They should also be able to tolerate antibiotics in order to aid re-
colonisation of the gut, during antibiotic therapy.  
Therefore, the aim of this project was to examine possible effects of 
environmental and physiological stresses on various functional properties of 
probiotic microorganisms, with specific interest in Bifidobacterium spp., using 
in vitro studies. Specific objectives of this project were: 
 to identify conditions for inducing acid, bile, oxidative and osmotic 
stresses in the bifidobacterial strains studied; 
 to assess the effect of exposure to these stresses on the functional 
properties, namely antimicrobial activity, biofilm formation and 
antibiotic susceptibility profile,  in comparison with controls 
(unstressed cells); and 
 to provide insight into how the functional properties of probiotic 
microorganisms may be affected due to exposure to stressful 
conditions and discuss possible implications. 
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CHAPTER TWO: ESTABLISHMENT OF STRESS TREATMENT 
CONDITIONS 
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2.1 Introduction  
Microorganisms intended for probiotic use are preferably of human intestinal 
origin, an environment in which their existence is relatively stress-free, as it is 
nutrient-rich, anaerobic and of neutral pH (Corcoran et al. 2008). When 
selected for probiotic use, however, these microorganisms become exposed 
to various stressful conditions. Conditions which are outside the optimum can 
be considered as stressful. These may be classed as suboptimal, sublethal 
and lethal (Ray and Bhunia 2008).   
Optimum conditions for bifidobacteria are typically anaerobic, with a pH 
between 6.5 – 7, and temperature between 37 – 41 °C (Tamime et al. 1995). 
However they can survive suboptimal conditions, as stress 
tolerance/response mechanisms are elicited upon exposure. Under such 
suboptimal conditions, growth can still occur due to adaptation, though at a 
slower rate. Sublethal conditions may usually result in sublethal injury, and it 
is less likely that growth would occur, until the cells are under optimum 
conditions and repair has occurred. Lethal conditions would usually cause 
irreparable damage and cell death. 
Yoghurt, which is a common vehicle for delivery of probiotics, usually has a 
pH of 4.5. As such, bifidobacteria are usually added after fermentation has 
ended, in the required numbers since no growth will occur during 
storage/refrigeration. Furthermore, the stomach pH ranges between 1 – 3, 
and this is potentially lethal to bifidobacteria during passage in the 
gastrointestinal tract. Transit time in the gut can range between 1 – 4 hours 
(Li et al. 2010).  
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The estimated physiological bile concentration in the human GIT is between 
0.3 – 2% (w/v) (Noriega et al. 2004). Bifidobacteria can tolerate bile 
concentrations of up to 2% (w/v), but this varies with the type of strain 
(Margolles et al. 2003; Jia et al. 2010). 
The osmolarity of the upper small intestine is equivalent to 0.3M NaCl, which 
suggests high salt concentration and low water activity (aw) (Sheehan et al. 
2007; Alvarez-Ordonez et al. 2011). Similar osmolarity can be achieved by 
supplementing the medium with 1.5% (w/v) NaCl or 6% (w/v) sucrose 
(Sheehan et al. 2007).  Concentrations of NaCl in physiological 
gastrointestinal conditions are not less than 0.5% (w/v), and in food 
fermentations range up to 6-8% (w/v) (Collado and Sanz 2007). 
The processses of manufacture and storage of probiotic-containing food 
products expose probiotic strains to aerobic conditions. The toxic effect of 
oxygen is considered one of the main factors influencing the survival of 
bifidobacteria in probiotic yoghurts (Talwalkar et al. 2004; Ruiz et al. 2012). 
Steep oxygen gradients may also be present in the gastrointestinal tract 
(Corcoran et al. 2008). Tolerance to oxygen is therefore desirable in 
probiotics, to ensure stability and viability in end products (Ruiz et al. 2012).  
The aim of this chapter was to examine the survival of different bifidobacteria 
under varying levels of acid, bile, osmotic and oxidative conditions in order to 
select sublethal stress conditions which could elicit stress in the 
bifidobacteria without being lethal. The expectation was that no growth would 
occur under such sublethal conditions, thus forming the basis of their 
selection, as no growth would be indicative of stress and/or sublethal injury in 
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the cells. These selected conditions would then be used to induce stress in 
the bifidobacteria prior to subsequent experiments in the further chapters. 
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2.2 Materials and methods 
2.2.1 Bacterial cultures 
Bifidobacterial cultures were made available from the culture collection of the 
Microbiology Research Unit of London Metropolitan University, namely 
Bifidobacterium breve NCTC 11815, B. longum NCTC 11818 (National 
Collection of Type Cultures, Collindale, UK), and two strains of B. animalis 
ssp. lactis, designated C and D. B. breve NCTC 11815 was of human origin, 
isolated from the intestine of an infant.  B. longum NCTC 11818 was also of 
human origin, isolated from the intestine of an adult. B. animalis ssp. lactis (C) 
was isolated from a commercial culture, Bifidobacterium BB-12, kindly 
provided by Chr. Hansen (Berkshire, UK). B. animalis ssp. lactis (D) was of 
dairy origin, isolated from a fermented dairy product of mixed microbial 
culture. Both were confirmed as B. animalis ssp. lactis by 16S rRNA gene 
sequencing. All cultures were stored on beads in cryovials (Microbank, Pro-
Lab Diagnostics UK) and kept at -20 ºC. Cultures were streaked on 
Reinforced Clostridial Agar (RCA) (CM 0151; Oxoid, Hampshire, UK) and 
incubated under anaerobic conditions (10% CO2, 10% H2, 80% N2) in an 
anaerobic cabinet (Don Whitley Scientific, UK) for 48 hours at 37 ºC. The 
resulting colonies were used for subsequent experiments. 
 
2.2.2 Inoculum preparation 
Colonies from a 48-hour culture were suspended in normal saline (8.5 g/L 
NaCl solution) to achieve an optical density equivalent to 0.5 McFarland 
using a Sensititre nephelometer (Trek Diagnostics, UK). 
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2.2.3 Survival under acid conditions 
 A 1 ml volume of the suspension was inoculated into 19 ml of MRSc broth 
(de Man, Rogosa, Sharpe broth, Oxoid CM0359 + 0.05% w/v L-cysteine 
hydrochloride) in 25 ml screw-capped Universal bottles, adjusted to pH 2.0, 
3.0 and 4.0 using 2M hydrochloric acid (HCl). The pH of the MRSc broths 
were adjusted after autoclaving. The control set up was unadjusted MRSc 
broth (pH 6.2). Enumeration was done on RCA at the point of inoculation 
(Time 0), and after 1, 2, 3 and 24 hours of incubation. The cultures were 
incubated under anaerobic conditions at 37 ºC. Experiments were carried out 
in duplicate. 
 
2.2.4 Survival in the presence of bile  
A 1 ml volume of the suspension was inoculated into 19 ml of MRSc broth in 
25 ml screw-capped Universal bottles, supplemented with ox-bile (B-3883; 
Sigma, St. Louis, USA) to reach ox-bile concentrations of 0.5% (w/v) and 1% 
(w/v). A stock solution of 10% (w/v) ox-bile was prepared in sterile distilled 
water and filter sterilised using a Nalgene 0.2 µm pore-size syringe filter 
(Thermo Scientific, UK). The MRSc broths were supplemented with 
appropriate quantities of bile solution after autoclaving, to achieve the final 
concentrations of 0.5% (w/v) and 1% (w/v). The control set up was non-
supplemented MRSc broth. Enumeration was done on RCA at the point of 
inoculation (Time 0), and after 1, 2, 3 and 24 hours of incubation. The 
cultures were incubated under anaerobic conditions at 37 ºC. Experiments 
were carried out in duplicate. 
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2.2.5 Survival under osmotic conditions 
A 1 ml volume of the suspension was inoculated into 19 ml of MRSc broth in 
25 ml screw-capped Universal bottles, supplemented with sodium chloride 
(NaCl) (Sigma) to achieve concentrations of 1%, 2%, 3%, 4% and 5% (w/v). 
The media were supplemented with NaCl before autoclaving. The control set 
up was non-supplemented MRSc broth. Enumeration was done on RCA at 
the point of inoculation (Time 0), and after 2, 4 and 24 hours of incubation. 
The cultures were incubated under anaerobic conditions at 37 ºC. 
Experiments were carried out in duplicate. 
 
2.2.6 Survival under oxidative conditions 
A 1 ml volume of the suspension was inoculated into 19 ml of MRSc broth in 
25 ml screw-capped Universal bottles and incubated under anaerobic 
conditions for 24 hours. Cells were harvested by centrifugation (26,700 x g 
for 15 minutes) and resuspended in 100 ml MRS broth in 250 ml conical 
flasks. Flasks were incubated in a shaking incubator with shaking speed of 
200 rpm at 37 ºC and enumeration was done at point of inoculation (Time 0), 
and after 2, 4 and 24 hours. The control set up was in MRSc broth incubated 
under anaerobic conditions in 100 ml Duran bottles, with no shaking. 
Experiments were carried out in duplicate. 
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2.3 Results 
2.3.1 Survival under acid conditions 
Cultures were inoculated in MRSc broth of pH 2, 3 or 4 and enumerated at 0, 
1, 2, 3 and 24 hours to monitor survival in acidic conditions. For all cultures, 
pH 2 proved to be very inhibitory, with no colonies recovered after one hour 
from the undiluted sample (Fig. 2.1a). At pH 3, the B. animalis ssp. lactis 
strains showed good survival over the 24 hour period, while no B. longum 
and B. breve colonies were recoverable after one hour from the undiluted 
sample (Fig. 2.1b). At pH 4, all cultures showed good survival over the 24 
hour period (Fig. 2.1c). 
 
2.3.2 Survival in the presence of bile  
Cultures were inoculated in MRSc broth of 0.5% or 1% (w/v) bile and 
enumerated at 0, 1, 2, 3 and 24 hours to monitor survival in the presence of 
bile. Generally colonies were recoverable after 24 hours under both 
conditions, except B. longum, where colonies were not recovered from the 
undiluted sample at 3 and 24 hours. All showed no large reduction in 
numbers after one hour of exposure to both 0.5% (Fig. 2.2a) and 1% (w/v) 
bile (Fig. 2.2b), except B. longum, which fared better after one hour of 
exposure to 0.5% than 1% (w/v) bile. 
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Fig. 2.1a Enumeration of bifidobacteria in MRSc broth with pH adjusted to pH 2, at 0, 
1, 2, 3 and 24 hours after incubation. Error bars represent standard error of the 
mean (SEM)  
 
 
Fig. 2.1b Enumeration of bifidobacteria in MRSc broth with pH adjusted to pH 3, at 0, 
1, 2, 3 and 24 hours after incubation. Error bars represent standard error of the 
mean (SEM)  
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Fig. 2.1c Enumeration of bifidobacteria in MRSc broth with pH adjusted to pH 4, at 0, 
1, 2, 3 and 24 hours after incubation. Error bars represent standard error of the 
mean (SEM)  
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Fig. 2.2a Enumeration of bifidobacteria in MRSc broth containing 0.5% (w/v) bile, at 
0, 1, 2, 3 and 24 hours after incubation. Error bars represent standard error of 
the mean (SEM)  
 
 
Fig. 2.2b Enumeration of bifidobacteria in MRSc broth containing 1% (w/v) bile, at 0, 
1, 2, 3 and 24 hours after incubation. Error bars represent standard error of the 
mean (SEM)  
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2.3.3 Survival under varying osmotic conditions 
Cultures were inoculated in MRSc broth of 1%, 2%, 3%, 4% or 5% (w/v) 
NaCl and enumerated at 0, 2, 4 and 24 hours to monitor survival in the 
presence of NaCl. Fig. 2.3 shows survival of the bifidobacteria under osmotic 
conditions. At NaCl concentrations of 1% and 2% (w/v) growth was observed 
after 24 hour incubation for B. animalis ssp. lactis strains (Fig. 2.3a and 2.3b) 
and B. breve (Fig. 2.3c). However, at concentrations from 3% (w/v) and 
above, no growth was observed, and no marked reduction was observed in 
the first 2 hours. For B. longum (Fig. 2.3d), no growth was observed under 
osmotic conditions, but survival after 24 hours was observed up to 2% (w/v) 
NaCl. No colonies were recovered from the undiluted sample after 24 hours 
at NaCl concentrations above 2% (w/v) for B. longum. 
 
2.3.4 Survival under oxidative conditions 
Cultures were inoculated in MRS broth and incubated in a shaking incubator 
at 200 rpm to aerate the medium. Fig. 2.4 shows survival under aerobic 
conditions. In general, under aerobic conditions, no colonies were recovered 
from the undiluted samples after 24 hours. However, there was no large 
reduction in numbers within the first two hours of aerobic incubation. 
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Fig. 2.3a Enumeration of B. animalis ssp. lactis (strain D) in MRSc broth adjusted to 
different NaCl concentrations (0%, 1%, 2%, 3%, 4%, 5%) at 0, 2, 4 and 24 hours 
after incubation. Error bars represent standard error of the mean (SEM)  
 
Fig. 2.3b Enumeration of B. animalis ssp. lactis (strain C) in MRSc broth adjusted to 
different NaCl concentrations (0%, 1%, 2%, 3%, 4%, 5%) at 0, 2, 4 and 24 hours 
after incubation. Error bars represent standard error of the mean (SEM)  
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Fig. 2.3c Enumeration of B. breve in MRSc broth adjusted to different NaCl 
concentrations (0%, 1%, 2%, 3%, 4%, 5%) at 0, 2, 4 and 24 hours after incubation. 
Error bars represent standard error of the mean (SEM)  
 
 
Fig. 2.3d Enumeration of B. longum in MRSc broth adjusted to different NaCl 
concentrations (0%, 1%, 2%, 3%, 4%, 5%) at 0, 2, 4 and 24 hours after incubation. 
Error bars represent standard error of the mean (SEM)  
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Fig. 2.4 Enumeration of bifidobacteria in MRS broth at 0, 2, 4 and 24 hours after 
incubation, under aerobic incubation (shaking at 200 rpm). Error bars represent 
standard error of the mean (SEM) 
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2.4 Discussion 
Commercial probiotic microorganisms are exposed to several environmental 
stresses, during large-scale production and product storage, and during 
passage through the oral cavity, stomach and small intestine. These stresses 
include oxygen and oxygen-derived radicals, acids, bile, osmotic, heat and 
cold stress, which could negatively affect viability and functionality (Zomer et 
al. 2009).  
Stress may be manifested in microorganisms in different ways, and these 
manifestations can be identified by various methods. Stress can result in 
changes in cell morphology, which can be identified by microscopic 
examination (Wesche et al. 2009). For instance, bifidobacteria exposed to 
oxidative stress showed intracellular granule formation and changes in shape 
when stained with simple stains like safranin or Loeffler’s methylene blue and 
examined under a microscope (Qian et al. 2011). Stress can also result in 
membrane damage, and this can be identified by flow cytometry. Ben Amor 
et al. (2002) were able to distinguish between live, dead and injured 
bifidobacteria after bile stress, using multiparameter flow cytometer, involving 
three dyes – propidium iodide (PI) stains dead cells, carboxyfluorescein 
diacetate (cFDA) stains intact cells, and bis-(1,3-dibutylbarbituric acid) 
trimethine oxonol [DiBAC4(3)] stains injured cells. 
Another method of confirming injury in microorganisms is by following repair 
of injury in their cells in a repair medium. This can be done by differential 
plating on restrictive medium, as described by Mackey (2000). The method is 
based on the theory that injured bacteria will not be able to grow on 
restrictive media, such as selective media, on which they would otherwise 
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grow if intact. The selective media would be inhibitory to injured bacteria, 
possibly due to membrane damage, for instance. Enumeration is done on 
selective and non-selective or optimum media. The optimum medium 
estimates the entire population while the selective medium estimates the 
healthy portion of cells. As enumeration is performed at intervals, and repair 
occurs, colonies are formed on the selective medium, and the counts 
increase with time. This has mainly been demonstrated in bacteria such as 
Campylobacter jejuni, Escherichia coli, Salmonella and Listeria 
monocytogenes (Wesche et al. 2009); no reports have been found for 
assessment of repair in lactic acid bacteria and bifidobacteria.    
Different stress conditions can affect cells in different ways, and the effects 
would usually be identified by certain methods. For the purpose of this study 
where different stress conditions were being studied, it was considered more 
practical to use an effect which was more universal irrespective of the type of 
stress factor, and which could be assessed using minimal resources. 
Therefore, the effect of stress on growth was selected as the criterion for 
determining stress in cells. A similar technique was carried out by McMahon 
et al. (2007b) to determine sublethal stress conditions of NaCl, pH and 
temperature stresses for Salmonella, Staphylococcus aureus and E. coli. 
Different NaCl concentrations, pH values and temperatures were assessed 
and growth was monitored for 24 hours by optical density readings at 600 nm 
(OD600). The sublethal stress levels of each stressor were determined as that 
at which a 75% reduction in OD600 of stressed cultures was observed, 
compared to that of the unstressed (control) cultures.     
 
70 
 
In this present study, survival under low pH was assessed at pH values of 2, 
3, and 4 for up to 3 hours, and then 24 hours. Similar conditions have been 
used in various other studies to assess acid tolerance of lactobacilli and 
bifidobacteria, such as Prasad et al. (1998), Collado and Sanz (2007), Bao et 
al. (2010), Jia et al. (2010) and Faye et al. (2012). Assessing survival up to 3 
hours is reflective of the time spent by food in the stomach (Maragkoudakis 
et al. 2006). Food transit time through the stomach is at least 1.5 hours 
(Chou and Weimer 1999). Studying higher pH (i.e. pH 4) is reflective of the 
increase in pH that could occur in the stomach due to ingesting a meal, or 
the probiotic delivery medium (e.g. yoghurt) (Vernazza et al. 2006a). 
Furthermore, fermented food products have a pH of about 4.5, in which 
probiotic microorganisms have to survive for long periods during refrigerated 
storage (Jia et al. 2010). 
At pH 2, there were no recoverable cells after 24 hours, and hourly 
enumeration showed no recoverable cells even after 1 hour, indicating that it 
was an extreme condition (Fig. 2.1a). At pH 3, B. animalis ssp. lactis strains 
C and D showed better survival than B. breve and B. longum (Fig. 2.1b) and 
all the strains showed better survival at pH 4 (Fig. 2.1c). Sanchez et al. 
(2010a) also observed drastic loss in viability of B. animalis ssp. lactis at pH 
2, and no loss in viability at pH 3. Vernazza et al. (2006a) reported that the 
Bifidobacterium spp. studied showed better survival at pH 3 and pH 4, while 
pH 2 was lethal. The B. lactis strain (Bb12) they studied showed good 
survival at all three pH values (2, 3 and 4). B. animalis ssp. lactis, which is 
more commercially used, has been known to show greater acid tolerance in 
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comparison to other non-commercial bifidobacteria (Maus and Ingham 2003), 
and this is consistent with the results of this study. 
The acid tolerance of bifidobacteria of human origin, such as B. breve, B. 
longum, B. bifidum, B. infantis and B. adolescentis have been shown to be 
generally weaker in comparison to those of animal origin (Collado and Sanz 
2007; Russell et al. 2011). The poorer acid tolerance of B. breve and B. 
longum in comparison to B. animalis ssp. lactis observed in this present 
study may be due to the lack of an inducible acid tolerance response (ATR) 
(Waddington et al. 2010).   
In this study, survival in the presence of bile was assessed at bile 
concentrations of 0.5% and 1% (w/v). Some studies have assessed bile 
tolerance at 0.3% (w/v), while others have assessed it at higher 
concentrations, from 0.5 % (w/v) up to 1-2% (w/v) (Margolles et al. 2003; 
Maragkoudakis et al. 2006; Vernazza et al. 2006a; Pan et al. 2009; Bao et al. 
2010). The average physiological concentration of bile in humans ranges 
between 0.3 to 0.5% (w/v) (Wu et al. 2010). However, this fluctuates with 
time, being about 1.5% to 2% (w/v) within the first hour of digestion, and 
decreasing to around 0.3% (w/v) (Noriega et al. 2004). No growth occurred in 
the presence of either 0.5% or 1% (w/v) bile, in this study. Growth may have 
occurred at lower concentrations, as shown in Margolles et al. (2003), but 
this may depend on the strain or species. B. longum appeared to be more 
sensitive to bile than B. animalis ssp. lactis and B. breve, as survival was 
observed after 24 hours in all except B. longum (Fig. 2.2). A similar pattern 
was observed in the study of Vernazza et al. (2006a), where the B. longum 
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strains showed undetectable counts in the presence of 0.5% (w/v) bile, in 
contrast to the B. animalis ssp. lactis strain, which showed higher counts. 
Growth of the bifidobacteria in this present study appeared to be inhibited in 
the presence of higher NaCl content i.e. 3% (w/v) and above. This may imply 
that there was excessive movement of water from the cells into the 
environment (Corcoran et al. 2008). In this study, B. longum appeared to be 
more sensitive to osmotic conditions than B. animalis ssp. lactis and B. breve, 
since no growth after 24 hours was observed in the presence of NaCl (1% 
and above) (Fig. 2.3). 
The lack of growth in the bifidobacteria in this study under aerobic conditions 
(Fig. 2.4) may confirm that they are indeed obligate anaerobes. Shaking at 
the speed of 200 rpm provided fully aerobic conditions, as reported by Li et al. 
(2010). However, the fact that there was no immediate reduction in numbers 
in the initial hours sampled may suggest that the bifidobacteria were able to 
tolerate oxygen to some extent. Growth of different species and strains of 
bifidobacteria in the presence of varying amounts of oxygen has been 
reported (Simpson et al. 2005; Xiao et al. 2011). B. animalis ssp. lactis has 
been reported to be more resistant to oxidative stress than bifidobacteria of 
human origin (Jayamanne and Adams 2006; Ruiz et al. 2012).   
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2.5 Conclusion 
Whilst bifidobacteria may be exposed to extreme conditions in the gut, the 
food they are ingested with may act as a buffer against extreme pH in the 
stomach. Similarly, the concentration of bile reduces with time. In reality, the 
amount of individual stresses that probiotics are exposed to would vary with 
circumstances. The conditions in this study were decidedly more extreme in 
order to ensure a state of stress in the organisms under study.  
Based on the above results, using the criteria of conditions which did not 
result in growth after 24 hours, and did not result in loss of viability within 1-2 
hours of exposure, the selected stress treatment parameters for the 
subsequent experiments were as follows: 
 Acid stress: pH 3 for 1 hour for B. animalis ssp. lactis strains, and pH 
4 for 1 hour for B. breve and B. longum. 
 Bile stress: 1% (w/v) bile for 1 hour for B. animalis ssp. lactis strains 
and B. breve, and 0.5% (w/v) bile for 1 hour for B. longum. 
 Osmotic stress: 3% (w/v) NaCl for 1 hour for B. animalis ssp. lactis 
strains and B. breve, and 2% (w/v) NaCl for 1 hour for B. longum. 
 Oxidative stress: Shaking at 200 rpm for 2 hours for all organisms. 
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CHAPTER THREE: EFFECTS OF STRESS ON 
ANTIMICROBIAL ACTIVITY OF BIFIDOBACTERIUM SPP. 
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3.1 Introduction 
Antagonistic activity against pathogens is one of the desirable properties of 
microorganisms selected for probiotic use. Reduction of intestinal pH by 
production of short chain fatty acids (e.g. lactic acid, acetic acid), production 
of bacteriocins and other substances which are inhibitory to several intestinal 
pathogens, stimulation of the immune system, and competition against 
pathogens for nutrients and for intestinal adhesion sites, are possible 
mechanisms through which probiotic bifidobacteria and lactobacilli could 
elicit potential health benefits, such as treatment of gastrointestinal infections 
(Toure et al. 2003; Makras and De Vuyst 2006; Wohlgemuth et al. 2010).  
Production of short chain fatty acids, i.e lactic acid and acetic acid, is 
suggested as the main mechanism by which bifidobacteria may inhibit 
enteric pathogens (Fliss et al. 2010). Bifidobacteria metabolise sugars via the 
unique fructose-6-phosphate phosphoketolase (F6PPK) pathway to produce 
2 molecules of lactate and 3 molecules of acetate (Sela et al. 2010) (see Fig. 
1.3). Inhibition of enteric bacteria may result from the lowering of pH by the 
organic acids, but also from the effects of the undissociated organic acid 
molecules. In this regard, acetic acid is considered to be a more potent 
antimicrobial than lactic acid, as its higher pKa value allows it to diffuse 
across the cell membrane at higher pH. However, the ratio of lactic to acetic 
acid production in bifidobacteria varies with strain/species as well as culture 
conditions (Fliss et al. 2010). 
Other antimicrobial substances ascribed to bifidobacteria include 
bacteriocins and bacteriocin-like inhibitory substances (BLIS). Bacteriocins 
are low-molecular-mass proteins synthesised in the ribosomes and released 
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extracellualrly, which exert bacteriostatic or bactericidal effects on other 
bacteria (Cheikhyoussef et al. 2009). Bacteriocin production in lactobacilli 
and other lactic acid bacteria (LAB) has been well reported, but fewer reports 
are available for bifidobacteria (Cheikhyoussef et al. 2008).  
Only one bacteriocin, Bifidocin B, produced by a B. bifidum strain, has been 
purified and sequenced and characterised (Yildirim et al. 1999). Bifidocin B 
has been shown to exert antimicrobial activity against food-borne pathogens 
and food spoilage bacteria like Listeria, Enterococcus, Bacillus, Pediococcus, 
Leuconostoc (Cheikhyoussef et al. 2009). Other bacteriocins from 
bifidobacteria which have been purified or partially purified include Bifidin and 
Bifilong (Cheikhyoussef et al. 2008; Fliss et al. 2010). The term BLIS mainly 
refers to proteinaceous inhibitory compounds obtained from bifidobacteria 
which have not been confirmed as bacteriocins (Fliss et al. 2010). Various 
studies have reported the presence of BLIS (Lee et al. 2003; Toure et al. 
2003; Collado et al.  2005) 
Antimicrobial activity is initially assessed in vitro on agar by the presence and 
size of inhibition zones. Assays include the agar overlay (spot test) and agar 
well diffusion (Tejero-Sarinena et al. 2012). Inhibition zones are clear zones 
around a bacterial colony or cell-free metabolites, where no growth of 
another type of bacteria is observed. Inhibition zones indicate a suppression 
of one type of bacteria by another (Vinderola et al. 2008). Potential probiotic 
bacteria would be desired to show inhibition zones on agar against different 
enteric pathogens, as this indicates a potential for health benefit. 
Antimicrobial activity may also be assessed by co-culture of two types of 
bacteria in liquid medium. A decline in the numbers of one type of bacteria in 
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the presence of another, may be indicative of antimicrobial/antagonistic 
activity of one against the other (Drago et al. 1997). 
Bifidobacteria have been demonstrated to exhibit antimicrobial activity 
against various Gram negative bacteria, such as Salmonella enterica ser. 
Typhimurium, Shigella sonnei and Escherichia coli (Hutt et al. 2006; Makras 
and De Vuyst 2006) and Gram positives such as Clostridium difficile (Lee et 
al. 2003), Listeria monocytogenes (Toure et al. 2003), and Staphylococcus 
aureus, to a lesser extent (Lahtinen et al. 2007). 
Whilst there is knowledge about in vitro antimicrobial activity of probiotic 
bacteria against pathogens under normal conditions, as well as the influence 
of culture conditions on the amounts of organic acids produced (Talwalkar 
and Kailasapathy 2003; Jalili et al. 2009; Marianelli et al. 2010), there are no 
known recorded studies about the antimicrobial activity of probiotic bacteria 
after exposure to sub-lethal stress conditions, particularly those encountered 
during gut transit. Thus this chapter examined the possible effects of the 
exposure of bifidobacteria to individual stress conditions on their potential for 
antimicrobial activity against pathogenic bacteria.  
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3.2 Materials and Methods 
3.2.1 Bacterial cultures 
Bifidobacterial cultures were namely Bifidobacterium breve NCTC 11815, B. 
longum NCTC 11818, B. animalis ssp. lactis strain C and B. animalis ssp. 
lactis strain D, as described in 2.2.1. Indicator bacteria cultures (pathogens) 
were made available from the Microbiology Research Unit culture collection, 
namely Escherichia coli NCTC 12900, Salmonella enterica ser. Typhimurium 
DT124 and S. enterica ser. Enteritidis PT4. All cultures were stored on beads 
in cryovials (Microbank, Pro-Lab Diagnostics UK) and kept at -20 ºC. 
Cultures were streaked on nutrient agar and incubated aerobically for 18-24 
hours at 37 ºC. The resulting colonies were used for subsequent agar spot 
and well diffusion experiments. 
 
3.2.2 Stress treatment 
3.2.2.1 Acid stress 
Colonies from 48-hour cultures on Reinforced Clostridial Agar (RCA) were 
suspended in 5 ml MRSc broth (MRS + 0.05% w/v L-cysteine) adjusted to pH 
3 or pH 4 (using hydrochloric acid) till a turbid suspension was achieved. 
Suspensions were incubated under anaerobic conditions at 37 ºC for 1 hour. 
Cells were harvested by centrifuging at 16,100 x g for 10 minutes and 
supernatant discarded. Pellets were resuspended in normal saline and 
adjusted to turbidity equivalent to 0.5 McFarland. 
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3.2.2.2 Bile stress 
Colonies from 48-hour cultures on RCA were suspended in 5 ml MRSc broth 
containing 0.5 or 1% w/v ox-bile (B-3883; Sigma, St. Louis, USA) till a turbid 
suspension was achieved. Suspensions were incubated under anaerobic 
conditions at 37 ºC for 1 hour. Cells were harvested by centrifuging at 16,100 
x g for 10 minutes and supernatant discarded. Pellets were resuspended in 
normal saline and adjusted to turbidity equivalent to 0.5 McFarland. 
 
3.2.2.3 Oxidative stress 
Colonies from 48-hour cultures on RCA were suspended in 20 ml MRS broth 
and incubated under anaerobic conditions for 24 hours. Cells were harvested 
by centrifuging at 26,700 x g for 15 minutes and supernatant discarded. 
Pellets were suspended in 50 ml MRS broth contained in 250 ml conical 
flasks and incubated aerobically in a shaking incubator at 37 ºC for 2 hours 
with shaking at 200 rpm. Cells were harvested by centrifuging at 16,100 x g 
for 10 minutes and supernatant discarded. Pellets were resuspended in 
normal saline and adjusted to turbidity equivalent to 0.5 McFarland.   
 
3.2.2.4 Osmotic stress 
Colonies from 48-hour cultures on RCA were suspended in 5 ml MRSc broth 
containing 2% or 3% (w/v) sodium chloride till a turbid suspension was 
achieved. Suspensions were incubated under anaerobic conditions at 37 ºC 
for 1 hour. Cells were harvested by centrifuging at 16,100 x g for 10 minutes 
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and supernatant discarded. Pellets were resuspended in normal saline and 
adjusted to turbidity equivalent to 0.5 McFarland. 
 
3.2.2.5 Unstressed cells 
Colonies from 48-hour cultures on RCA were suspended in 5 ml unadjusted 
MRSc broth till a turbid suspension was achieved. Suspensions were 
incubated under anaerobic conditions at 37 ºC for 1 hour. Cells were 
harvested by centrifuging at 16,100 x g for 10 minutes and supernatant 
discarded. Pellets were resuspended in normal saline and adjusted to 
turbidity equivalent to 0.5 McFarland. 
 
3.2.3 Agar overlay (spot test) 
A 2 µl aliquot of each suspension of bifidobacteria (stressed or unstressed) 
was spotted on RCA (up to four spots per plate, in duplicate). Plates were left 
to dry at room temperature for 30 minutes and afterwards incubated at 37 ˚C 
for 18-24 h under anaerobic conditions. Resulting colonies were overlaid with 
10 ml soft agar (tryptone soya broth (CM 0129, Oxoid) + 0.8% w/v agar (LP 
0013, Oxoid) at 45 ˚C which were seeded with 100 µl of suspensions 
(adjusted to 0.5 McFarland turbidity) of overnight cultures of indicator 
bacteria. Overlaid plates were incubated aerobically at 37 ˚C for 18-24 hours. 
Inhibition zones were measured and recorded in mm by subtracting the 
diameter of the colony from the diameter of the entire halo (Fig 3.1). Eight 
measurements from two experiments were taken and the means calculated. 
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Fig. 3.1 A typical agar overlay (spot test) showing inhibition zones around 
bifidobacterial colonies 
 
3.2.4 Agar well diffusion assay 
A 200 µl volume of each stressed or unstressed bifidobacterial suspension 
was inoculated into 20 ml of Reinforced Clostridial Medium (RCM) (CM 0149; 
Oxoid, Hampshire, UK) and incubated under anaerobic conditions for 24 
hours. The overnight cultures were centrifuged at 26,700 x g for 15 minutes 
and the supernatants were separated from the pellets and sterilised through 
a Nalgene 0.2 µm pore-size syringe filter (Thermo Scientific, UK). The sterile 
supernatants were concentrated to approximately one-twentieth of the 
original volume, using a vacuum evaporator system (Buchi UK Ltd), and 
used for the agar well diffusion assay. The supernatants were concentrated 
because Toure et al. (2003) reported a failure of unconcentrated 
supernatants of bifidobacteria to produce inhibition, which was recovered by 
concentration of the supernatants. Twenty ml volumes of soft TSA 
(containing 0.8% w/v agar) were seeded with 200 µl of suspensions 
(adjusted to 0.5 McFarland turbidity) of overnight cultures of indicator 
bacteria, poured into sterile Petri dishes and allowed to solidify at 5 ˚C for 2 
hours. Wells of 7 mm diameter were punched into the solidified agar and 
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filled with 100 µl of the concentrated sterile supernatants. The plates were 
kept at 5 ˚C for 2 hours to allow diffusion of the tested supernatants and then 
incubated aerobically at 37 ˚C for 18-24 hours. Inhibition zones were 
measured and recorded in mm by subtracting the diameter of the well from 
the diameter of the entire halo (Fig. 3.2). Six measurements from two 
experiments were taken and the means calculated.     
 
 
Fig. 3.2 A typical agar well diffusion assay showing an inhibition zone around a well 
 
3.2.5 Study of acidification rate 
Two ml volumes of each 0.5 McFarland turbidity adjusted bifidobacterial 
suspension (unstressed, acid, bile and osmotically stressed) were inoculated 
into 200 ml of RCM in sterile magnetically-stirred 300 ml water jacketed 
batch fermentation vessels (Soham Scientific, UK) and incubated under 
anaerobic conditions at 37 ˚C. The temperature was controlled by means of 
a circulating water bath set at 37 ˚C. The pH of each vessel was monitored 
by pH electrodes inserted into the vessels (FerMac 260 pH Control, 
Electrolab, UK), which were connected to a data logger (eLogger, Electrolab, 
UK). Acidification was monitored over a 48 hour period, with data logged at 
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regular intervals. These experiments were carried out in three replicates and 
mean pH at each interval was calculated. 
 
3.2.6 Enumeration of pathogens in co-culture with bifidobacteria 
Twenty ml volumes of RCM were inoculated with 200 µl of suspensions (0.5 
McFarland turbidity) of overnight cultures of E. coli NCTC 12900 or 
Salmonella enterica ser. Typhimurium DT124, either on their own, or with 
200 µl of suspensions (adjusted to 0.5 McFarland turbidity) of each of the 
bifidobacteria of different stress exposure treatments (unstressed, acid, bile, 
osmotic), and incubated under anaerobic conditions at 37 ˚C. These 
experiments were carried out in duplicate. Enumeration of the pathogens 
was done on Violet Red Bile Glucose (VRBG) agar (Oxoid CM1082). VRBG 
plates were incubated at 37 ˚C aerobically for 18-24 hours. 
 
3.2.7 Statistical analysis 
Data from the agar overlay and agar well diffusion assay were analysed by 
Student’s t-test to compare unstressed and stressed data groups, using 
Microsoft Excel 2007. Statistical significance was set at P ≤ 0.05. 
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3.3 Results 
3.3.1 Antimicrobial activities by agar overlay 
Fig. 3.3 shows comparisons of antimicrobial activities against the indicator 
organisms by the agar overlay, for the tested bifidobacteria after prior 
exposure to stress conditions. Antimicrobial activity was quantified by the 
diameters of the inhibition zones (mm). Overall, unstressed B. breve and B. 
longum showed larger inhibition zones than both B. animalis ssp. lactis 
strains. Also, inhibitory activities of all four bifidobacteria were maintained 
after exposure to stress. B. breve and B. longum exposed to acid stress 
showed significantly smaller inhibition zones for all three indicator bacteria.  
Acid-stressed B. animalis ssp. lactis (C) showed no significant difference in 
inhibition zone sizes, while acid-stressed B. animalis ssp. lactis (D) showed 
significantly smaller inhibition zones for E. coli and S. Enteritidis (Fig. 3.3a).  
Bile-stressed B. breve showed smaller inhibition zones for all three indicator 
bacteria, while bile-stressed B. longum showed significantly smaller inhibition 
zones for E. coli and S. Typhimurium. Bile-stressed B. animalis ssp. lactis (C) 
showed larger inhibition zones, but only significantly for S. Typhimurium, 
while bile-stressed B. animalis ssp. lactis (D) showed significantly smaller 
inhibition zones for both salmonellae, and no significant difference for E. coli 
(Fig. 3.3b).  
Osmotically stressed B. animalis ssp. lactis C and D showed significantly 
smaller inhibition zones for S. Typhimurium and E. coli respectively. 
Significantly smaller inhibition zones for both salmonellae were observed by 
osmotically stressed B. breve and B. longum (Fig. 3.3c).  
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Oxidatively stressed B. animalis ssp. lactis (C) and B. longum showed 
significantly smaller inhibition zones for all three indicator bacteria. B. breve 
exposed to oxidative stress showed significantly smaller inhibition zones for 
both salmonellae, and B. animalis ssp. lactis exposed to oxidative stress 
showed significantly larger inhibition for S. Typhimurium, with no significant 
difference for the other two indicator bacteria (Fig. 3.3d). 
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Fig. 3.3a Inhibition zones (mm) of bifidobacteria against indicator organisms by agar 
overlay after exposure to acid stress. Error bars represent standard error of the 
mean (SEM). Asterisks represent significant differences (P ≤ 0.05) 
 
 
Fig. 3.3b Inhibition zones (mm) of bifidobacteria against indicator organisms by agar 
overlay after exposure to bile stress. Error bars represent standard error of the 
mean (SEM). Asterisks represent significant differences (P ≤ 0.05) 
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Fig. 3.3c Inhibition zones (mm) of bifidobacteria against indicator organisms by agar 
overlay after exposure to osmotic stress. Error bars represent standard error of 
the mean (SEM). Asterisks represent significant differences (P ≤ 0.05) 
 
 
Fig. 3.3d Inhibition zones (mm) of bifidobacteria against indicator organisms by agar 
overlay after exposure to oxidative stress. Error bars represent standard error of 
the mean (SEM). Asterisks represent significant differences (P ≤ 0.05) 
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3.3.2 Antimicrobial activities assessed by agar well diffusion 
To further examine whether exposure to stress had an effect on the inhibitory 
substances released into the medium, antimicrobial activities of cell-free 
supernatants were assessed by agar well diffusion. Fig. 3.4 shows 
comparisons of antimicrobial activities against the indicator organisms 
between the stressed and unstressed bifidobacteria, by the agar well 
diffusion assay. Antimicrobial activity was quantified by the diameters of the 
inhibition zones (mm). As observed in the agar spot test, supernatants of 
unstressed B. breve and B. longum showed larger inhibition zones than both 
B. animalis ssp. lactis strains. Also, inhibitory activities of all four 
bifidobacteria were maintained after exposure to stress.  
The supernatants of acid-stressed B. animalis ssp. lactis (C), B. breve and B. 
longum showed significantly smaller inhibition zones than supernatants from 
unstressed cells, for all three indicator bacteria, while that for acid-stressed B. 
animalis ssp. lactis (D) showed significantly smaller inhibition for only S. 
enteritidis (Fig. 3.4a).  
Bile-stressed B. breve and B. longum supernatants showed significantly 
smaller inhibition for all indicator bacteria, while that for B. animalis ssp. lactis 
(D) showed significantly smaller inhibition for S. Enteritidis only. No 
significant differences in inhibition were observed for by supernatants of bile-
stressed B. animalis ssp. lactis (C) (Fig. 3.4b).  
No significant differences in inhibition by supernatants of osmotically 
stressed bifidobacteria were observed except in those of B. longum 
supernatants, where significantly smaller inhibition occurred (Fig. 3.4c).  
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Supernatants of B. animalis ssp. lactis (C), B. breve and B. longum exposed 
to oxidative stress showed significantly smaller inhibition zones for all 
indicator bacteria, while those for oxidatively stressed B. animalis ssp. lactis 
(D) showed significantly smaller inhibition for only S. Enteritidis (Fig 3.4d). 
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Fig. 3.4a Inhibition zones (mm) of bifidobacteria against indicator organisms by agar 
well diffusion after exposure to acid stress. Error bars represent standard error of 
the mean (SEM). Asterisks represent significant differences (P ≤ 0.05) 
 
 
Fig. 3.4b Inhibition zones (mm) of bifidobacteria against indicator organisms by agar 
well diffusion after exposure to bile stress. Error bars represent standard error of 
the mean (SEM). Asterisks represent significant differences (P ≤ 0.05) 
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Fig. 3.4c Inhibition zones (mm) of bifidobacteria against indicator organisms by agar 
well diffusion after exposure to osmotic stress. Error bars represent standard 
error of the mean (SEM). Asterisks represent significant differences (P ≤ 0.05) 
 
 
Fig. 3.4d Inhibition zones (mm) of bifidobacteria against indicator organisms by agar 
well diffusion after exposure to oxidative stress. Error bars represent standard 
error of the mean (SEM). Asterisks represent significant differences (P ≤ 0.05) 
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3.3.3 Acidification rates 
To examine whether reductions in inhibition zones after exposure to stress 
were due to impact of stress-exposure on pH reduction, acidification rates, 
i.e. pH reduction, by B. animalis (strain C), B. breve and B. longum exposed 
to acid, bile and osmotic stress, were monitored by a data logger. Oxidative 
stress was not included due to time constraint. Fig. 3.5 shows graphs for 
acidification of bifidobacteria of different stress treatments.  
The acidification patterns of B. animalis ssp. lactis (C) (Fig. 3.5a) exposed to 
acid, bile and osmotic stresses appeared to be similar to the pattern of the 
unstressed. Acidification patterns of acid and osmotically stressed B. breve 
were also similar to the unstressed. Acidification in B. breve exposed to bile 
appeared to be considerably slower than the unstressed in the first 30 hours, 
after which it sped up considerably, such that the final pH at the 48 hour 
point was similar to the other treatments (Fig. 3.5b).  
Acidification by B. longum exposed to acid, bile and osmotic stress appeared 
to be faster than the unstressed, and the final pH values at 48 hours were all 
considerably lower than the unstressed. Acidification by B. longum exposed 
to bile was particularly faster than other treatments (Fig. 3.5c). 
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Fig. 3.5a Acidification in RCM by unstressed and stress-treated (acid, bile, osmotic) 
B. animalis subsp. lactis (strain C). Error bars represent standard error of the mean 
(SEM)   
 
 
Fig. 3.5b Acidification in RCM by unstressed and stress-treated (acid, bile, osmotic) 
B. breve. Error bars represent standard error of the mean (SEM)   
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Fig. 3.5c Acidification in RCM by unstressed and stress-treated (acid, bile, osmotic) 
B. longum. Error bars represent standard error of the mean (SEM)  
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3.3.4 Co-culture 
To further study the effect of stress on the antimicrobial activity of 
bifidobacteria, enumeration of two indicator organisms used in the agar spot 
and well diffusion assays, namely E. coli NCTC 12900 and S. Typhimurium 
DT124, was carried out on VRBG agar, which is selective for 
Enterobacteriaceae and does not support the growth of bifidobacteria. Both 
bacteria were cultured in RCM with each of the four bifidobacteria, which had 
been unstressed or exposed to acid, bile or osmotic stress.  
Figs. 3.6 – 3.9 show the counts of E. coli and S. Typhimurium on their own 
and in co-culture with bifidobacteria of different stress treatments, at 0, 24 
and 48 hours. There was growth of E. coli and S. Typhimurium cultured 
alone after 24 and 48 hours. In general, growth of E. coli and S. Typhimurium 
was better sustained up to 48 hours when cultured on their own than in co-
culture, with few exceptions. 
Growth was observed in E. coli co-cultured with B. animalis ssp. lactis (D) of 
different stress treatments after 24 hours, though less than E. coli cultured on 
its own. Counts of E. coli co-cultured with unstressed B. animalis ssp. lactis 
(D) at 24 hours were slightly lower than with stressed B. animalis ssp. lactis 
(D). After 48 hours, counts of E. coli in co-culture with B. animalis ssp. lactis 
(D) were lower than at the 24 hour point. Counts of E. coli co-cultured with 
acid-stressed B. animalis ssp. lactis (D) appeared to be lower in comparison 
to others, at the 48 hour enumeration (Fig. 3.6a). 
Growth was observed in S. Typhimurium in co-culture with B. animalis ssp. 
lactis (D) of different stress treatments after 24 hours. Counts were lower 
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than S. Typhimurium cultured alone, except for counts of S. Typhimurium co-
cultured with bile-stressed B. animalis ssp. lactis (D), which were better than 
even S. Typhimurium cultured on its own. After 48 hours, decline was 
observed in S. Typhimurium in co-culture, except for S. Typhimurium in co-
culture with bile-stressed B. animalis ssp. lactis (D), where counts were still 
similar to the 24 hour enumeration.  There also appeared to be greater 
decline in counts of S. Typhimurium co-cultured with acid-stressed B. 
animalis ssp. lactis (D), in comparison to others, at 48 hours (Fig. 3.6b). 
Little growth was observed after 24 hours in S. Typhimurium co-cultured with 
B. animalis ssp. lactis (C) of different stress treatments, except for that co-
cultured with osmotically-stressed B. animalis ssp. lactis (C), where better 
growth was observed than S. Typhimurium cultured on its own. After 48 
hours, no further growth was observed in S. Typhimurium in co-culture with B. 
animalis ssp. lactis (C). Decline was observed in the counts of S. 
Typhimurium co-cultured with acid-stressed and bile-stressed B. animalis 
ssp. lactis (C), and counts of S. Typhimurium co-cultured with osmotically 
stressed B. animalis ssp. lactis (C) remained similar to the 24 hour counts, 
showing only slight decline (Fig. 3.7a). 
Growth was observed in E. coli co-cultured with B. animalis ssp. lactis (C) of 
different stress treatments after 24 hours, but less than E. coli cultured on its 
own, with the exception of E. coli co-cultured with osmotically-stressed B. 
animalis ssp. lactis (C), which had growth similar to E. coli cultured alone. 
After 48 hours, decline was observed in counts of E. coli co-cultured with 
acid-stressed and bile-stressed B. animalis ssp. lactis (C), while little change 
was observed in 48-hour counts of E. coli co-cultured with unstressed and 
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osmotically-stressed B. animalis ssp. lactis (C), in comparison to 24-hour 
counts (Fig. 3.7b). 
Decline was observed in S. Typhimurium co-cultured with unstressed and 
osmotically-stressed B. breve after 24 hours, while growth was observed in S. 
Typhimurium co-cultured with acid-stressed and bile-stressed B. breve, with 
better growth in the S. Typhimurium co-cultured with bile-stressed B. breve, 
in comparison to S. Typhimurium cultured on its own. After 48 hours, decline 
was also observed in the S. Typhimurium co-cultured with acid-stressed and 
bile-stressed B. breve, though counts were better for S. Typhimurium co-
cultured with bile-stressed B. breve (Fig. 3.8a). 
Growth was observed in E. coli co-cultured with B. breve of different stress 
treatments after 24 hours. Counts at 24 hours were better in co-culture with 
unstressed and bile-stressed B. breve, with counts in co-culture with bile-
stressed B. breve being similar to E. coli cultured on its own.  After 48 hours, 
decline was generally observed in E. coli counts, with larger decline 
observed in E. coli co-cultured with unstressed and acid-stressed B. breve, in 
comparison to E. coli co-cultured with osmotically-stressed B. breve. Slight 
decline was observed in E. coli co-cultured with bile-stressed B. breve (Fig. 
3.8b). 
Growth was observed in S. Typhimurium co-cultured with B. longum of 
different stress treatments after 24 hours, with the least growth observed in 
co-culture with acid-stressed B. longum. After 48 hours, large decline was 
observed in S. Typhimurium counts in co-culture with B. longum, with the 
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least decline shown by S. Typhimurium co-cultured with bile-stressed B. 
longum (Fig. 3.9a). 
Growth was observed in E. coli co-cultured with B. longum of different stress 
treatments after 24 hours. Counts were similar to that of E. coli cultured on 
its own. After 48 hours, decline was observed generally, with the least and 
most decline observed in E. coli co-cultured with bile-stressed and 
osmotically-stressed B. longum respectively (Fig. 3.9b) 
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Fig. 3.6a Enumeration on VRBG agar of E. coli in co-culture with B. animalis ssp. 
lactis (strain D) treatments at 0, 24 and 48 hours. Error bars represent standard error 
of the mean (SEM) 
 
 
Fig. 3.6b Enumeration on VRBG agar of S. Typhimurium in co-culture with B. 
animalis ssp. lactis (strain D) treatments at 0, 24 and 48 hours. Error bars represent 
standard error of the mean (SEM) 
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Fig. 3.7a Enumeration on VRBG agar of S. Typhimurium in co-culture with B. 
animalis ssp. lactis (strain C) treatments at 0, 24 and 48 hours. Error bars represent 
standard error of the mean (SEM) 
 
 
Fig. 3.7b Enumeration on VRBG agar of E. coli in co-culture with B. animalis ssp. 
lactis (strain C) treatments at 0, 24 and 48 hours. Error bars represent standard error 
of the mean (SEM) 
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Fig. 3.8a Enumeration on VRBG agar of S. Typhimurium in co-culture with B. breve 
treatments at 0, 24 and 48 hours. Error bars represent standard error of the mean 
(SEM) 
 
 
Fig. 3.8b Enumeration on VRBG agar of E. coli in co-culture with B. breve 
treatments at 0, 24 and 48 hours. Error bars represent standard error of the mean 
(SEM) 
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Fig. 3.9a Enumeration on VRBG agar of S. Typhimurium in co-culture with B. 
longum treatments at 0, 24 and 48 hours. Error bars represent standard error of the 
mean (SEM) 
 
 
Fig. 3.9b Enumeration on VRBG agar of E. coli in co-culture with B. longum 
treatments at 0, 24 and 48 hours. Error bars represent standard error of the mean 
(SEM) 
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3.4 Discussion 
This study was aimed at investigating the effect of exposure to stress on the 
in vitro antimicrobial activity of bifidobacteria. This was initially assessed by 
agar overlay (spot test), and then, agar well diffusion. Whereas the spot test 
involves the presence the Bifidobacterium colonies, and therefore, direct cell-
to-cell contact with the indicator organisms, the well diffusion method 
involves only cell-free supernatants. It was carried out to confirm whether 
inhibition required direct cell contact, or if it was due to 
metabolites/substances released into the medium. The fact that inhibition 
occurred in the well diffusion method may suggest that inhibition is due to the 
latter.   
According to the sizes of inhibition zones in the unstressed state, the 
antimicrobial activities of the four bifidobacteria studied could be ranked, 
from highest to lowest, as B. breve, B. longum, B. animalis ssp. lactis (C) and 
B. animalis ssp. lactis (D). This pattern was the same in both agar overlay 
and agar well diffusion methods. The study of Tejero-Sarinena et al. (2012) 
similarly found that the B. breve strain used in their study showed the most 
potent antagonistic effect against pathogenic bacteria, among the 
bifidobacteria used, although no B. animalis ssp. lactis strain was included.  
It is interesting that the unstressed B. animalis ssp. lactis strains in this 
present study showed lower inhibitory activity than the unstressed B. breve 
and B. longum strains, although B. animalis ssp. lactis is considered as a 
strong acid producer. A possible explanation could be that it produced more 
lactic acid than acetic acid, as observed in the B. animalis ssp. lactis Bb12 
used in the study of Hutt et al. (2006), and lactic acid is considered less 
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inhibitory than acetic acid, because acetic acid has a higher pKa, allowing it 
to diffuse across the cell membrane at higher pH (Fliss et al. 2010). Acetic 
acid has a low molecular weight and greater liposolubility, which allows it to 
penetrate bacterial membranes faster than lactic acid (Fernandez et al. 
2009). Nonetheless, lactic acid makes the outer membrane of Gram negative 
bacteria more permeable to other inhibitory compounds (Makras et al. 2006).  
As B. animalis ssp. lactis is highly used commercially, it may be suggested 
that one of the reasons for its wide use is that it does not produce as much 
acetic acid, which is known to result in off-flavours and off-odours in 
fermented dairy products (Margolles and Sanchez 2012). However, it is not 
clear whether the B. longum and B. breve strains used in this study produce 
lactic acid and acetic acid in different quantities to the B. animalis ssp. lactis 
strains. Quantities of lactic and acetic acid produced have been shown to 
differ with strain type (Makras and De Vuyst 2006).  
In contrast to the explanation that acetic acid is more inhibitory than lactic 
acid, the study of Tejero-Sarinena et al. (2012) showed that higher 
production of lactic acid was correlated with greater pH reduction and 
consequently increased inhibition, whereas higher production of acetic acid 
did not influence pH and inhibition significantly. The strains of bifidobacteria 
used in their study, i.e. B. longum, B. bifidum and B. breve, all produced 
significantly higher amounts of lactic acid than acetic acid, except B. infantis, 
which produced more acetic acid than lactic acid, and also showed the least 
potent inhibitory activity against the pathogens used in the study.  
105 
 
Therefore it may be possible that other inhibitory substances, apart from 
organic acids, were produced by unstressed B. breve and B. longum, which 
may account for the higher inhibition in comparison to B. animalis ssp. lactis 
observed in this present study. However, this was not investigated. If it were 
investigated, it would have involved the neutralisation of the cell-free 
supernatants and then assessing inhibition by well diffusion. The presence of 
inhibition zones would be suggestive of other antimicrobial substances such 
as bacteriocins and BLIS (Bevilacqua et al. 2003). Furthermore, the 
contribution of other antimicrobial substances by bifidobacteria in inhibiting 
Gram negative pathogens, has been considered to be negligible (Makras 
and De Vuyst 2006). The higher inhibition observed by B. breve and B. 
longum in this study may simply be due to the production of more lactic acid. 
In both agar overlay and agar well diffusion methods, there was inhibition of 
indicator organisms observed in stressed and unstressed bifidobacteria. 
However, in many cases, there were significantly smaller inhibition zone 
diameters in stressed treatments relative to the unstressed, and this may 
imply reduced antimicrobial activity after exposure to stress. It could be 
suggested that the metabolism of the cells may have been affected, such 
that less organic acid was produced, though it is not clear how their 
metabolism may be affected by stress, to then lead to change in organic acid 
production. It may also be plausible to suggest that exposure to stress 
caused extended lag phases, allowing for repair of injury, such that by the 
time the experiment was stopped, the amount of inhibitory substances 
released in the medium were not as much as in the unstressed state. 
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Shah and Ravula (2000) found that reduced water activity of probiotic 
yoghurt due to sugar (sucrose) addition (12-16%) resulted in increased 
fermentation times and decreased levels of acetic and lactic acid and 
increased pyruvic acid production (HPLC analysis). This may be an 
indication that stressful conditions could affect carbohydrate metabolism. 
Similar effects on lactic acid and acetic acid production with varying aeration 
(oxygen levels) were observed by Talwalkar and Kailasapathy (2003), 
Marianelli et al. (2010) and Ruiz et al. (2012).  Furthermore, studies by 
Sanchez et al. (2005) on B. longum NCIMB 8809 reported up-regulation of 
the F6PPK enzyme activity and changes in the metabolic end products 
(lactate, acetate) in the presence of bile, with a reduction in acetate/lactate 
ratio. The implications this alteration in acid ratio may have on antimicrobial 
activity and its consequent effects in vivo are not certain.   
To shed light on the impact of stress exposure on growth and metabolism 
rates, the acidification rate was studied. The rate at which the pH of the 
medium is lowered may be related to the growth/metabolism rate. In B. 
animalis ssp. lactis (C), the pattern of acidification did not differ much 
between the unstressed and stressed treatments, although the acid-stressed 
and bile-stressed treatments had slightly slower acidification, as the pH 
values were still higher at the 24-hour point. By the 48-hour point, the pH 
values were similar (Fig. 3.5a). The effect of stress on acidification rate was 
more clearly demonstrated in B. breve, where exposure to bile slowed down 
acidification considerably. Conversely, osmotic stress appeared to speed up 
acidification. However, by the 48-hour point as well, the pH values were 
similar (Fig 3.5b). In B. longum, the unstressed culture appeared to have a 
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slower acidification rate compared to the stressed, with the bile-stressed 
treatment showing the fastest acidification. The pH values at the 48-hour 
point were also similar, for the stressed treatments (Fig. 3.5c). 
Relating the acidification patterns to the agar overlay and well diffusion 
methods, it may be suggested that the impact of stress on pH is more 
pronounced in the earlier stages, and this may corroborate the smaller 
inhibition zones observed in the well diffusion assay, since supernatants 
were obtained after 24 hours of growth of the stressed bifidobacteria. This 
may also be down to extended lag phases. However, the fact that the pH 
values after 48 hours were similar for stressed and unstressed treatments 
may suggest that there are differences in the quantities of organic acid in the 
medium, after exposure to stress, as corroborated by smaller inhibition zones 
observed in the agar overlay (spot test), where the bifidobacteria were 
incubated for a total of 48 hours. Lactic acid and acetic acid are both 
produced during the exponential phase and the stationary phase of growth of 
bifidobacteria, but more in the exponential phase (Jalili et al. 2009). 
The effect of exposure to stress on the pH in the earlier stages of incubation 
may be further supported by results from the co-culture experiments. 
Although there were no consistent differences between stressed and 
unstressed cells, it could be noticed that there was usually growth of the E. 
coli or S. Typhimurium after 24 hours, and then decline after 48 hours. This 
may be due to the fact the probiotics have longer lag phases and generation 
times than Salmonella spp. and E. coli, such that they are able to grow 
before the bifidobacteria could express their antimicrobial activity (Marianelli 
et al. 2010). Better growth of E. coli or S. Typhimurium in co-culture with 
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stressed bifidobacteria, relative to those co-cultured with unstressed 
bifidobacteria, may suggest that the ability of the bifidobacteria to reduce pH, 
which consequently affects the growth of E. coli and S. Typhimurium, has 
been impeded, most likely due to the effect of stress on the lag phase.   
Inhibition by bifidobacteria may be more due to the action of the 
undissociated organic acids themselves, than just the reduction in pH caused 
by organic acid production. Organic acids have been shown to cause more 
inhibition of S. Typhimurium than hydrochloric acid (inorganic acid) at the 
same pH (Makras and De Vuyst 2006). The study by Alvarez-Ordonez et al. 
(2010) showed that, from highest to lowest, the order of acids in inhibiting S. 
Typhimurium was acetic, lactic, citric, hydrochloric. Organic acids, which are 
weak acids, penetrate cell membranes of bacteria as undissociated 
molecules. They dissociate intracellularly, causing a reduction in cytoplasmic 
pH, thereby affecting the metabolic activities of the cell (Pan et al. 2009; 
Alvarez-Ordonez et al. 2010).   
It may also require mentioning that RCM, which was used for growing 
bifidobacteria for the well diffusion experiment, and also used for the co-
culture experiments, contains sodium acetate (3 g/L). Sodium acetate, as a 
form of acetic acid, can be inhibitory to some bacteria. This was 
demonstrated by De Keersmaecker et al. (2006), who observed 20% 
inhibitory activity of sterile MRS (pH 4.5) against S. Typhimurium. This 
inhibitory activity was partially attributed to the sodium acetate content 
(60mM) of MRS. 
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3.5 Conclusion 
Despite the apparent reduction in antimicrobial activity that can occur upon 
exposure of bifidobacteria to some stresses, there was still antimicrobial 
activity nonetheless. Reduction in antimicrobial activity of bifidobacteria 
exposed to stress appears to be most likely due to extended lag phases. It is 
not clear whether exposure to stress may cause genetic changes that could 
be translated to altered antimicrobial activity. Moreover, it is possible that 
effects of stress on antimicrobial activity observed in vitro may not be 
translated in vivo. More evidence would be required from further studies, as 
there is still a poor understanding of the mechanisms of probiotic action. This 
is the first known study looking directly at the effects of exposure to stress on 
the specific property of antimicrobial activity. It may be possible that in the 
future, assessment of antimicrobial activity of known stress-tolerant 
bifidobacteria would be conducted with prior exposure to stress, as this may 
paint a more representative picture of what applies in reality. 
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CHAPTER FOUR: EFFECTS OF STRESS ON ANTIBIOTIC 
SUSCEPTIBILITY PROFILES OF BIFIDOBACTERIUM SPP. 
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4.1 Introduction 
Antibiotics have been widely used in the treatment of bacterial infections, 
since the discovery of penicillin in 1928 by Alexander Fleming. However, the 
overuse and misuse of antibiotics has led to a problem of antibiotic 
resistance, where bacteria become resistant to antibiotics which they were 
previously susceptible to. Bacteria can be intrinsically or naturally resistant to 
antibiotics, whereby the antibiotic targets are absent in the bacterial species, 
or there is low cell permeability, the presence of efflux mechanisms, or 
inactivation of the antibiotics. Some bacteria may acquire antibiotic 
resistance genes, thus contributing to the spread of the resistance problem 
(Saarela et al. 2000; Ammor et al. 2008b; EFSA 2008).  
Bacteria which may be potentially used as probiotics are usually screened for 
the presence of antibiotic resistance genes, and the potential for spread to 
other bacteria, particularly pathogens. The fact that probiotic bacteria are 
added to various products makes them a potential source for the spread of 
antibiotic resistance genes (D’Aimmo et al. 2007).  
Sensitivity to antibiotics may be considered as a desirable feature for 
probiotic microorganisms, as it is considered a safety concern, should they 
possess antibiotic resistance genes. Resistance genes are of concern when 
they are carried on mobile genetic elements (plasmids), which may be 
transferred between bacteria via horizontal gene transfer mechanisms such 
as conjugation, transduction and transformation. Intrinsic resistance is 
unlikely to be transmitted (Zhou et al. 2005; Ammor et al. 2008b; Gueimonde 
et al. 2010). 
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Antibiotic therapy has been known to disrupt the intestinal microbial balance, 
leading to antibiotic-associated diarrhoea. Probiotics with intrinsic antibiotic 
resistance may be useful for treatment of such conditions (Zhou et al. 2005; 
Hammad and Shimamoto 2010). Probiotics may be co-administered with 
antibiotics during treatment of intestinal infections, to prevent or alleviate 
antibiotic-associated diarrhoea and other related gastrointestinal symptoms, 
by restoring the intestinal microbial balance (Katz 2006; Saarela et al. 2007). 
Tolerance of probiotic microorganisms to antibiotics can be considered a 
useful trait in this regard, as the organisms would not be affected by 
antibiotic therapy (Yazid et al. 2000; Masco et al. 2006; Vernazza et al. 
2006b).  
The susceptibility or resistance of bacteria to antibiotics can be established 
qualitatively or quantitatively. Qualitative determination involves diffusion of 
the antibiotic from a disc into agar. Quantitative assessment is by the 
determination of the minimum inhibitory concentration (MIC). This can be 
determined by a series of two-fold dilutions of the antibiotic in broth or agar. 
The MIC is the lowest concentration of an antibiotic that can inhibit microbial 
growth (Masco et al. 2006; EFSA 2008).   
Sub-lethal environmental stress has been demonstrated to alter antibiotic 
resistance in some food-related pathogens such as Escherichia coli, 
Staphylococcus aureus and Cronobacter sakazakii (McMahon et al. 2007b; 
Huang et al. 2009; Al-Nabulsi et al. 2011). The stress conditions 
bifidobacteria are exposed to may alter their physiological properties, as well 
as antibiotic susceptibility patterns. However, this has not been widely 
studied. Some studies on the effects of acid and bile on antibiotic 
113 
 
susceptibility patterns of lactobacilli have been documented (Charteris et al. 
2000; Elkins and Mullis 2004; Kheadr 2006). 
Studying possible modifications in susceptibility and resistance patterns due 
to exposure to stress would be useful in selecting probiotic microorganisms 
for prophylactic use (Kheadr et al. 2007). Therefore, this chapter examined 
whether exposure to stress conditions can affect the antibiotic 
resistance/susceptibility profiles of the bifidobacteria under study. 
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4.2 Materials and Methods 
4.2.1 Bacterial cultures 
Bifidobacterial cultures were namely Bifidobacterium breve NCTC 11815, B. 
longum NCTC 11818, B. animalis ssp. lactis strain C and B. animalis ssp. 
lactis strain D, as described in 2.2.1. 
 
4.2.2 Stress treatment 
The bifidobacteria (B. animalis ssp. lactis C and D, B. breve and B. longum) 
were exposed to acid, bile, osmotic and oxidative stress as described in 
3.2.2.1 – 3.2.2.4. Unstressed cells were prepared as described in 3.2.2.5. 
 
4.2.3 Determination of minimum inhibitory concentration (MIC) 
Two-fold (doubling) dilutions of antibiotics were prepared in Reinforced 
Clostridial Agar (RCA) using guidelines by the National Committee for 
Clinical Laboratory Standards (NCCLS 2000). Antibiotics (Sigma) and their 
concentrations used included tetracycline (0.25 – 64 µg/ml), chloramphenicol 
(0.3125 – 2 µg/ml), ampicillin (0.3125 – 2 µg/ml), vancomycin (0.3125 – 2 
µg/ml) and erythromycin (0.3125 – 2 µg/ml). Stock solutions of the antibiotics, 
at concentration of 1280 µg/ml, were prepared in appropriate solvents (detail 
below) and the dilution series were prepared in sterile distilled water. Stock 
solutions of tetracycline (tetracycline hydrochloride), ampicillin (sodium salt) 
and vancomycin (vancomycin hydrochloride) were prepared in sterile distilled 
water, while stock solutions of erythromycin and chloramphenicol were 
prepared in ethanol. The subsequent dilution series were prepared in sterile 
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universal bottles, to concentrations ten times the desired final concentration 
in agar. Sterilized RCA was allowed to reach 55 °C in a water bath and 1 ml 
of each solution from the dilution series was added to 9 ml of molten agar 
and poured into sterile petri dishes, i.e. 1:10 dilution to reach desired final 
concentration in agar. The control plates contained no antibiotic. All agar 
plates were allowed to set at room temperature, and kept refrigerated until 
time of use (maximum two weeks).  
The bacterial suspensions (0.5 McFarland turbidity) were diluted 1:10 in 
normal saline, to achieve a final concentration of approximately 107 cfu/ml. A 
2 µl aliquot of each suspension was spotted on each agar dilution plate. The 
plates were allowed to dry at room temperature for 30 minutes and then 
incubated under anaerobic conditions at 37 °C for 48 hours. Experiments 
were carried out in duplicate. The minimum inhibitory concentration (µg/ml) 
was considered as the lowest concentration of each antibiotic that completely 
inhibited growth.  
The bifidobacteria were classified as resistant or susceptible to the antibiotics 
studied, according to the microbiological breakpoints (cut-off values) defined 
by EFSA (2008). Breakpoints are defined by studying the distribution of MICs 
of an antibiotic within bacterial populations of a single genus or species. 
Parts of the population which deviate from the normal susceptible 
populations can be classified as resistant. This can be useful in identifying 
strains possessing acquired antibiotic resistance genes (Ammor et al. 2008b). 
Organisms were classified as susceptible to an antibiotic when inhibition 
occurred at breakpoint level of the specific antibiotic, and classified as 
resistant to an antibiotic when not inhibited at breakpoint level of the 
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antibiotic. Table 4.1 shows the EFSA (2008) microbiological breakpoints of 
the five antibiotics used in this study for Bifidobacterium spp. 
 
Table 4.1 Microbiological breakpoints for Bifidobacterium spp. 
Antibiotic Breakpoint (µg/ml) 
Ampicillin 2 
Vancomycin 2 
Erythromycin 0.5 
Tetracycline 8 
Chloramphenicol 4 
 
4.2.4 Survival in the presence of antibiotics 
Twenty ml of RCM containing tetracycline or chloramphenicol was inoculated 
with 200 µl aliquots of suspensions (0.5 McFarland turbidity) of B. breve or B. 
animalis ssp. lactis (strain C). B. breve suspensions were inoculated into 
RCM of 1 µg/ml tetracycline and 2 µg/ml chloramphenicol. B. animalis ssp. 
lactis (strain C) suspensions were inoculated into RCM of 32 µg/ml 
tetracycline and 2 µg/ml chloramphenicol. These were carried out in 
duplicate. Enumeration was done on RCA at 0, 3, 6, 24 and 48 hours. RCA 
plates were incubated under anaerobic conditions at 37°C for 48 hours.  
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4.2.5 Expression of tetracycline resistance gene tet(W)  in B. animalis 
ssp. lactis (C) by quantitative reverse transcription polymerase chain 
reaction (qRT-PCR) 
Colonies from 48-hour cultures of B. animalis ssp. lactis (strain C) on RCA 
were suspended in 5 ml MRSc broth adjusted to acid, bile or osmotic stress 
conditions, i.e. pH 3, 1% (w/v) bile or 3% (w/v) NaCl, and 5 ml unadjusted 
MRSc broth as control. Suspensions were incubated under anaerobic 
conditions at 37 ºC for 1 hour. Cells were harvested by centrifuging at 26,700 
x g for 15 minutes and the supernatant discarded. Pellets were resuspended 
in normal saline and adjusted to turbidity equivalent to 2 McFarland 
(approximately 6 x 108 cfu/ml). The final volume of each suspension was 10 
ml. Suspensions were stabilized using Qiagen RNAprotect Bacteria Reagent 
(Qiagen, UK) and RNA was then extracted by enzymatic lysis and 
mechanical disruption and purified using the Qiagen RNeasy Protect 
Bacteria Mini Kit, following the Qiagen RNAprotect Bacteria Reagent 
Handbook protocols. RNA integrity was assessed using the Agilent 
Bioanalyzer (Agilent, UK). RNA integrity number (RIN) > 9.3 for all samples 
indicated high RNA integrity. RNA purity and concentration were measured 
using a NanoDrop spectrophotometer (Thermo Scientific, UK). The A260/280 
ratio of >2 for all samples suggested high purity and A260/230 ratio of >1.8 
for all samples suggested high RNA concentration. Reverse transcription of 
RNA into complementary DNA (cDNA) with removal of genomic DNA (gDNA) 
contamination was carried out using the Qiagen QuantiTect Reverse 
Transcription Kit, following the QuantiTect Reverse Transcription Handbook 
protocol. Incubation was done using a Rotor-Gene 6000 cycler (Qiagen, UK). 
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In the quantitative polymerase chain reaction (qPCR), primers (Table 4.2) 
were used to amplify the tetracycline resistance gene tet(W) and reference 
genes atpD, tufA and ldh. The expression of the gene in B. animalis ssp. 
lactis only was studied because resistance to tetracycline was only displayed 
by B. animalis ssp. lactis C and D used in this study (see results). Due to 
time and cost, it was not feasible to study the expression in both strains, 
therefore only strain C was selected, as there was a higher MIC of 
tetracycline against it, compared to strain D (see results). The tet(W) primers 
used for B. animalis ssp. lactis were as described in Gueimonde et al. (2010) 
and supplied by Sigma-Aldrich, UK. For accurate gene quantification, the 
expression of the gene of interest, i.e. tet(W), was normalised to the 
expression of the reference genes, whose expression does not change 
under the various experimental conditions. The reference genes were as 
used by Foroni et al. (2011). The stability of these reference genes was 
assessed using the geNorm software. Reference gene primers were 
designed by qStandard Ltd, UK. Two µl of cDNA were amplified in a 10 µl 
reaction using the Brilliant III Ultra-Fast SYBR Green QPCR Master Mix 
(Agilent UK) with each primer at a final concentration of 500 nmol/L. 
Amplification was carried out in a Rotor-Gene 6000 cycler, under the 
following conditions: 1 cycle of 95 °C for 3 min followed by 40 cycles of 95 °C 
for 5 sec and 57 °C for 1 sec. Quantitative PCR was carried out in three 
replicates, and mean number of normalised copies per reaction was 
calculated. 
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Table 4.2 Primer sequences 
Gene Forward primer Reverse primer 
tet(W) 5’-GCCCGGCCACATGGAT-3’ 5’-GCCCCATCTAAAACAGCCAAA-3’ 
atpD 5’-CTCCACCTCGCGAATCCT-3’ 5’-GAAGTTCTGGCCGAGGAAC-3’ 
tufA 5’-GAGTACGACTTCAACCAGATCG-3’ 5’-ATGTTCTTCACGAAGTCGGC-3’ 
ldh 5’-CCGACATGGTCGTCATCAC-3’ 5’-GGGTTGGTGATGAGCATGTA-3’ 
 
4.2.6 Statistical analysis 
Gene expression data were analysed by Student’s t-test to compare 
unstressed and stressed data groups, using Microsoft Excel 2007. Statistical 
significance was set at P ≤ 0.05. 
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4.3 Results 
4.3.1 MIC determination 
The MICs of five antibiotics against bifidobacteria after exposure to acid, bile, 
osmotic and oxidative stress were determined by agar dilution, and 
compared against the MICs of the controls. Table 4.3 shows a summary of 
the MICs of the antibiotics used for the organisms and treatments tested, 
with indications of resistance (R) or susceptibility (S). All four bifidobacteria 
were sensitive to chloramphenicol, erythromycin, ampicillin and vancomycin. 
B. breve and B. longum were sensitive to tetracycline, while both B. animalis 
ssp. lactis strains were resistant to tetracycline.  
Overall there were few differences between MICs of stressed and unstressed 
bifidobacteria, and where differences occurred, they were only by one two-
fold dilution factor (higher or lower). Also, the stressed bifidobacteria 
remained in the same category (S or R) as the unstressed, where differences 
in MIC were observed. 
Differences in the MIC of chloramphenicol were only observed in B. breve 
exposed to acid, bile and oxidative stress, which appeared to have a lower 
MIC of chloramphenicol, in comparison to the unstressed. 
Differences in the MIC of erythromycin were observed in B. animalis ssp. 
lactis (C) exposed to osmotic and oxidative stress, which appeared to have a 
lower MIC of erythromycin and B. longum exposed to osmotic stress, which 
appeared to have a higher MIC of erythromycin, in comparison to the 
unstressed. Lower MICs were also observed in B. breve exposed to acid and 
bile stress.   
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Unstressed B. animalis ssp. lactis (C) appeared to have the lowest MIC of 
ampicillin of all four bifidobacteria studied. Higher MICs were observed in B. 
animalis ssp. lactis (C) exposed to osmotic and oxidative stress, in 
comparison to the unstressed. Higher MICs were also observed in B. 
animalis ssp. lactis (D) exposed to acid and osmotic stress, and B. breve 
exposed to acid stress, in comparison to the unstressed. Unstressed B. 
longum had the highest MIC, and when exposed to bile and oxidative stress, 
appeared to have lower MIC of ampicillin, in comparison to the unstressed.     
Vancomycin showed a higher MIC against B. animalis ssp. lactis (C) 
exposed to osmotic stress and lower MIC against oxidatively stressed B. 
animalis ssp. lactis (C). A lower MIC was observed in B. animalis ssp. lactis 
(D) exposed to osmotic stress, and in B. longum exposed to acid stress. 
Unstressed B. animalis ssp. lactis (C) appeared to have the highest MIC of 
tetracycline of all four bifidobacteria. Lower MIC was only observed in B. 
animalis ssp. lactis (C) exposed to oxidative stress. B. animalis spp. lactis (D) 
appeared to have higher MICs after exposure to bile and osmotic stress. B. 
breve and B. longum showed the lowest MIC of tetracycline, and only their 
acid-stressed treatments showed lower MICs of tetracycline.  
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Table 4.3 MICs (µg/ml) of five antibiotics against (1) B. animalis ssp. lactis (C) (2) B. animalis ssp. lactis (D) (3) B. breve and (4) B. 
longum after exposure to acid, bile, osmotic and oxidative stress 
 Chloramphenicol Erythromycin Ampicillin Vancomycin Tetracycline 
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1 1 
(S) 
1 
(S) 
1 
(S) 
1 
(S) 
1 
(S) 
0.125 
(S) 
0.125 
(S) 
0.125 
(S) 
0.0625 
(S) 
0.0625 
(S) 
0.0625 
(S) 
0.0625 
(S) 
0.0625 
(S) 
0.125 
(S) 
0.125 
(S) 
0.5 
(S) 
0.5 
(S) 
0.5 
(S) 
1 
(S) 
0.25 
(S) 
32 
(R) 
32 
(R) 
32 
(R) 
32 
(R) 
16 
(R) 
2 1 
(S) 
1 
(S) 
1 
(S) 
1 
(S) 
1 
(S) 
0.125 
(S) 
0.125 
(S) 
0.125 
(S) 
0.125 
(S) 
0.125 
(S) 
0.125 
(S) 
0.25 
(S) 
0.125 
(S) 
0.25 
(S) 
0.125 
(S) 
1 
(S) 
1 
(S) 
1 
(S) 
0.5 
(S) 
1 
(S) 
16 
(R) 
16 
(R) 
32 
(R) 
32 
(R) 
16 
(R) 
3 1 
(S) 
0.5 
(S) 
0.5 
(S) 
1 
(S) 
0.5 
(S) 
0.125 
(S) 
0.0625 
(S) 
0.0625 
(S) 
0.125 
(S) 
0.125 
(S) 
0.25 
(S) 
0.5  
(S) 
0.25 
(S) 
0.25 
(S) 
0.25 
(S) 
0.5 
(S) 
0.5 
(S) 
0.5 
(S) 
0.5 
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0.5 
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1 
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4 1 
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0.125 
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0.125 
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1  
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(S) 
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1 
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1 
(S) 
1 
(S) 
1 
(S) 
0.5 
(S) 
1 
(S) 
1 
(S) 
1 
(S) 
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4.3.2 Survival in the presence of antibiotics 
To further investigate the effects of exposure to stress on the susceptibility of 
bifidobacteria to antibiotics, B. animalis ssp. lactis (strain C) and B. breve 
were selected for enumeration in the presence of tetracycline and 
chloramphenicol at concentrations ≥ the MIC values of the unstressed, after 
exposure to acid, bile and osmotic stress. Figs. 4.1 and 4.2 show the survival 
of B. animalis ssp. lactis (strain C) and B. breve treatments in the presence 
of tetracycline (Fig. 4.1a and 4.2a) and chloramphenicol (Fig. 4.1b and 4.2b).  
Overall, the survival patterns of the different treatments were similar in both 
organisms. There appeared to be better survival in tetracycline than in 
chloramphenicol. However, the survival of both B. animalis ssp. lactis (strain 
C) and B. breve exposed to osmotic stress, in the presence of 
chloramphenicol, appeared to be better than those exposed to acid and bile, 
or unstressed. Also, bile-treated B. breve counts at Time 0 were much lower 
than the Time 0 counts for B. breve unstressed or exposed to acid and 
osmotic stresses. It is not clear if this was due to poor survival of exposure to 
bile before inoculating into the antibiotic-containing RCM, or if it was due to 
interaction of bile-treated B. breve with the antibiotics. 
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Fig. 4.1a Enumeration of B. animalis ssp. lactis (strain C) exposed to stress 
conditions in RCM of 32 µg/ml tetracycline, at 0, 3, 6, 24 and 48 hours. Error bars 
represent standard error of the mean (SEM) 
 
 
Fig. 4.1b Enumeration of B. animalis ssp. lactis (strain C) exposed to stress 
conditions in RCM of 2 µg/ml chloramphenicol, at 0, 3, 6, 24 and 48 hours. Error bars 
represent standard error of the mean (SEM) 
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Fig. 4.2a Enumeration of B. breve exposed to stress conditions in RCM of 1µg/ml 
tetracycline, at 0, 3, 6, 24 and 48 hours. Error bars represent standard error of the 
mean (SEM) 
 
 
Fig. 4.2b Enumeration of B. breve exposed to stress conditions in RCM of 2 µg/ml 
chloramphenicol, at 0, 3, 6, 24 and 48 hours. Error bars represent standard error of 
the mean (SEM) 
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4.3.3 Tetracycline resistance gene tet(W) expression 
Expression of tet(W), a gene involved in tetracycline resistance, was 
measured in B. animalis ssp. lactis exposed to acid, bile and osmotic stress, 
by qRT-PCR. There appeared to be significantly higher expression of tet(W) 
in B. animalis ssp. lactis (C) exposed to acid, bile and osmotic stress 
conditions, than in the unstressed (Fig. 4.3). The highest expression relative 
to the control was in the osmotically-stressed B. animalis ssp. lactis (C). 
 
 
Fig. 4.3 Expression of tet(W) under control, acid, bile and osmotic conditions. Error 
bars represent standard error of the mean (SEM). Asterisks represent 
significant differences in comparison to the control (P ≤ 0.05) 
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4.4 Discussion 
Bifidobacteria are generally very susceptible to Gram-positive spectrum 
antibiotics such as macrolides, erythromycin, teicoplanin, novobiocin, 
vancomycin; broad spectrum antibiotics such as rifampicin, chloramphenicol; 
and beta-lactams such as penicillin, ampicillin, amoxicillin, imipenem. Most 
Bifidobacterium spp. are resistant to Gram-negative spectrum antibiotics 
such as fusidic acid, nalidixic acid and polymyxin B; and aminoglycosides 
such as neomycin, kanamycin, streptomycin and gentamicin. They have also 
been found to show variable susceptibility to tetracycline and some 
cephalosporins (Lim et al. 1993; Zhou et al. 2005; Ammor et al. 2007). 
In this study, five antibiotics were used, each representing a different 
class/mode of action. Ampicillin, a penicillin derivative, belongs to the β-
lactam group, and the mode of action is via inhibition of cell wall synthesis 
(Mayo et al. 2010). Susceptibility to ampicillin and other penicillin derivatives 
in bifidobacteria is suggested to be due to the lack of β-lactamase production 
(Moubareck et al. 2005; Masco et al. 2006). Any resistance is most likely to 
be due to cell wall impermeability (Charteris et al. 1998). The organisms 
used in this present study were all susceptible to ampicillin (MIC ≤ 2 µg/ml) 
and exposure to stress did not make them resistant or more susceptible to 
ampicillin.  
Vancomycin is a glycopeptide, which acts by inhibition of cell wall synthesis, 
though at a different site than β-lactams (Mayo et al. 2010). Vancomycin is 
one of the last broadly effective antibiotics against infections caused by multi-
drug resistant pathogens, and resistance to vancomycin is therefore a 
concern. Varying levels of susceptibility to vancomycin have been reported in 
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bifidobacteria, though this has been suggested to be due to the type of 
method used for assessment (Zhou et al. 2005). However, the organisms in 
this study appeared to be susceptible to vancomycin (MIC ≤ 2 µg/ml), and 
this was consistent after exposure to stress.  
Erythromycin is a macrolide antibiotic, which inhibits ribosomal protein 
synthesis (Mayo et al. 2010). Bifidobacteria are highly susceptible to 
erythromycin (MIC ≤ 0.5 µg/ml) and the organisms used in this study 
displayed this, irrespective of stress exposure.  
Phenicol antibiotics such as chloramphenicol interfere with protein synthesis. 
Bifidobacteria are usually sensitive to chloramphenicol (Mayo et al. 2010). 
MICs > 4 µg/ml are considered to indicate resistance (EFSA 2008). The 
organisms in this study were all susceptible to chloramphenicol, and this did 
not change with exposure to stress. 
Tetracyclines are also inhibitors of ribosomal protein synthesis and 
bifidobacteria show variable levels of susceptibility (Mayo et al. 2010). MICs > 
8 µg/ml are considered to indicate resistance to tetracycline (EFSA 2008). In 
this present study, both B. animalis ssp. lactis strains were resistant to 
tetracycline, and this was maintained after exposure to stress. B. breve and 
B. longum were susceptible to tetracycline (MIC < 8 µg/ml) and this remained 
the case when exposed to stress.  
Tetracycline resistance is the most common antibiotic resistance in 
bifidobacteria, and the tet genes, such as tet(O), tet(M) and tet(W), which 
code for ribosomal protection proteins, are most commonly responsible for 
this trait. The most commonly detected gene in bifidobacteria is tet(W), which 
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is located on the bacterial chromosome (Kazimierczak et al. 2006; 
Gueimonde et al. 2010). The tet genes in Bifidobacterium are known to 
protect ribosomes from the action of tetracyclines (Gueimonde et al. 2013). 
Tetracycline-susceptible bifidobacteria have also been found to possess 
chromosomally encoded tet(W) genes (Ammor et al. 2008a).  
In this study, higher expression of tet(W) in B. animalis ssp. lactis after 
exposure to acid, bile and osmotic stress conditions was observed. 
Gueimonde et al. (2010) also observed slight induction of tet(W) in B. 
animalis ssp. lactis upon bile exposure. It could be suggested that this up-
regulation in the expression of tet(W) observed in this present study may be 
a protective mechanism, in response to stress conditions that can affect 
ribosomes in bacterial cells, since tet genes code for ribosomal protection 
proteins. This increased expression of tet(W) in B. animalis ssp. lactis did not 
however manifest as increased tetracycline resistance. 
Whilst the bifidobacteria used in this study were not demonstrated to 
possess any antibiotic resistance genes which are borne on mobile genetic 
elements (plasmids, transposons), it could be suggested that exposure of 
probiotic bacteria to stress may increase the transmission of antibiotic 
resistance plasmids, thereby contributing to the antibiotic resistance problem. 
For instance, the tet(W) gene of Bifidobacterium, though integrated in the 
bacterial chromosome, may often be surrounded by transposase target 
sequences, i.e. genes coding for transposases. Transposases are enzymes 
that catalyse the movement of DNA fragments between different locations, 
by recognising specific target sequences. This may suggest that under 
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adequate conditions, the tet(W) gene may be transferred (Kazimierczak et al. 
2006; Ammor et al. 2008a; Gueimonde et al. 2010).  
McMahon et al. (2007a) reported that under sublethal environmental stress 
conditions (pH, osmotic, high/low temperature), the horizontal transmission 
rates of the two plasmids studied (R386 and TP307), between plasmid-
bearing Escherichia coli donor cultures and recipient E. coli and Salmonella 
typhimurium strains, were significantly increased in comparison to control 
conditions. This may further justify the need to screen potential probiotic 
bacteria for the presence of antibiotic resistance genes, and the potential of 
transmission of those genes to pathogens, with the additional consideration 
of environmental stress. However, in vitro transferability may not necessarily 
imply transmission in vivo. There is currently no evidence to suggest that 
bifidobacteria can transfer antibiotic resistance to other enteric bacteria 
(Gueimonde et al. 2013). 
One group of antibiotics not included in the study is the aminoglycosides, 
which include gentamicin, kanamycin, neomycin and streptomycin. 
Aminoglycosides are also inhibitors of ribosomal protein synthesis, but 
bifidobacteria are generally intrinsically resistant to aminoglycosides, 
because, being anaerobes, they lack cytochrome-mediated drug transport 
(Mayo et al. 2010). It has been observed that exposure to treatments which 
affect the lipid bilayer of the cell membrane, i.e. detergents such as ox-bile, 
can increase susceptibility to aminoglycosides (Charteris et al. 2000).  
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The study by Kheadr et al. (2007) reported increased susceptibility of acid 
stressed bifidobacteria to ampicillin, vancomycin, aminoglycosides, 
chloramphenicol and erythromycin in varying levels. Bile-stressed 
bifidobacteria showed particularly increased susceptibility to aminoglycosides. 
This was considered to be due to enhanced cell wall permeability facilitated 
by ox-bile. Increased susceptibility to chloramphenicol, and erythromycin to 
some extent, was observed. Also, bile stress conferred resistance to 
tetracycline in most of the strains studied. Oxidatively stressed bifidobacteria 
showed increased susceptibility cell-wall directed β-lactams, chloramphenicol, 
erythromycin and tetracycline. This was attributed to alterations in membrane 
properties and disruption of membrane-bound proteins, as a result of attack 
of polyunsaturated fatty acids in the cell membranes by free radicals. 
Bacteria for probiotic use would preferably exhibit stress tolerant properties. 
It is possible that these stress tolerance mechanisms may interact with their 
resistance or susceptibility to antibiotics. Noriega et al. (2005) observed that 
bile-adapted strains of B. animalis and B. longum showed increased 
resistance to tetracyclines, though the mechanism by which this occurred 
was unclear. Similarly, Collado and Sanz (2007) observed that some acid-
resistant strains of Bifidobacterium were more resistant to antibiotics like 
ampicillin, tetracycline, penicillin and rifampicin. It was suggested that 
general modifications in cell permeability and surface properties may be 
responsible. 
While the bifidobacteria used in this study showed in vitro susceptibility to the 
antibiotics tested, it is possible that they would be able to survive better in 
vivo than in vitro, since survival is dependent on the antibiotic concentration. 
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Bifidobacteria are mainly located in the colon, and since antibiotics are 
mainly absorbed in the ileum, the therapeutic dosage which reaches the 
colon might be lower than the initial ingested dose, thereby allowing survival 
(Yazid et al. 2000; Moubareck et al. 2005).  
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4.5 Conclusion 
This study examined the effect of stress exposure on antibiotic susceptibility 
patterns of bifidobacteria. In general, there was no change from susceptibility 
to resistance, or vice-versa, according to the EFSA breakpoints. Changes in 
MIC were only by one dilution factor above or below, relative to the control. It 
is possible that these are fluctuations which may be due to interference from 
media, growth conditions and inoculum volume (EFSA 2008). The 
expression of the intrinsic tetracycline resistance gene in B. animalis ssp. 
lactis appeared to be higher after exposure to stress conditions. This 
however did not necessarily translate into higher MIC of tetracycline. It is 
possible that the stress tolerance mechanisms overlap with antibiotic 
susceptibility/resistance. However, if increased susceptibility to antibiotics 
occurs upon exposure to environmental stress, particularly where resistance 
to an antibiotic is intrinsic, this should be looked at further, to understand the 
mechanisms and implications for prophylactic use of probiotics against side 
effects of antibiotic therapy.  
 
 
 
 
 
 
 
134 
 
 
 
 
 
 
 
CHAPTER FIVE: EFFECTS OF STRESS ON BIOFILM 
FORMATION POTENTIAL OF BIFIDOBACTERIUM SPP. 
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5.1 Introduction 
Bifidobacteria are of intestinal origin, being one of the earliest colonizers of 
the gastrointestinal tract after birth, and predominate the intestinal microflora 
of breast-fed infants (O’Grady and Gibson 2005). Their human origin makes 
them good potential probiotic candidates, as they would be more likely to 
colonise the gut. After surviving transit through the gastrointestinal tract, 
probiotic microorganisms need to be able to colonise the gut temporarily.   
Adhesion to the intestinal epithelial cells (enterocytes) is considered as 
necessary for probiotic microorganisms to colonise the large intestine, and 
colonisation is important for beneficial health effects such as modulation of 
the immune system to be observed (Tuomola et al. 2001). By attaching to 
the epithelium, probiotics can compete with enteric pathogens and prevent 
their attachment to the epithelium i.e. competitive exclusion (Oelschlaeger 
2010; Wohlgemuth et al. 2010). Bifidobacteria have been shown to adhere 
very well to intestinal cells, which in turn can enable them to colonise the 
large intestine (Fliss et al. 2010).  
An outcome of adhesion may be the formation of biofilms. A biofilm is an 
aggregation of microorganisms within an extracellular polymeric matrix, 
usually polysaccharide, on a biotic or abiotic surface (Costerton et al. 1995). 
Biofilms are ubiquitous, being found in a range of different natural 
environments, including the human gastrointestinal tract (Probert and Gibson, 
2002). 
Biofilm formation is a complex process generally consisting of three stages: 
attachment, maturation and dispersion (Bjarnsholt et al. 2013). Biofilm-
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associated organisms are considered to exhibit very different properties from 
planktonic (unaggregated) organisms (Shemesh et al. 2007). Organisms 
within a biofilm are usually more resistant to adverse environmental 
conditions and antibiotics (Stepanovic et al. 2007; Xu et al. 2011).  
Most adherent bacteria occur in nature in biofilms, including the 
microorganisms in the gut (Lebeer et al. 2007). In the human gut, bacteria 
can exist as biofilms on the colonic epithelium, the mucus layer covering it, 
as well as on the surface of food particles (Probert and Gibson 2002). 
Bacteria which form biofilms on food particles are more likely to be involved 
in food digestion, which may give them an advantage when competing for 
available nutrients (Macfarlane and Macfarlane 2006). 
Biofilm formation in pathogens has been widely studied because of their 
implications for health. These studies have been carried out to understand 
the nature of biofilm formation in these pathogens, in order to devise suitable 
measures of controlling them (Xu et al. 2011). Pathogens which have been 
studied include Listeria monocytogenes (Begley et al. 2009; Sandasi et al. 
2010; Xu et al. 2011), Actinobacillus actinomycetemcomitans (Perez et al. 
2006), enterococci (Extremina et al. 2011), Streptococcus mutans (Shemesh 
et al. 2007), Salmonella (Speranza et al. 2011) and staphylococci 
(Stepanovic et al. 2007).  
Biofilm formation has been suggested to be influenced by nutrient availability, 
environmental conditions, as well as strain type. Such conditions include 
those found in the gastrointestinal environment, namely low pH, high 
osmolarity and the presence of bile (Lebeer et al. 2007). A common method 
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for quantifying biofilms in vitro is the crystal violet assay for cultures grown in 
microtitre plates (Stepanovic et al. 2007). 
The cell surface of bifidobacteria and other Gram-positive bacteria have 
been shown to have pili or fimbriae, which are hair-like appendages 
suggested to be involved in the attachment and colonisation of host tissues, 
and the development of biofilms (Foroni et al. 2011; Juge 2012). Many lactic 
acid bacteria and bifidobacteria produce exopolysaccharides (EPS), which 
are extracellular carbohydrate polymers. Suggested roles of EPS in 
bifidobacteria include cell recognition, adhesion to surfaces, formation of 
biofilms to enhance colonisation of various ecosystems, protection against 
host defences such as phagocytosis, and protection against osmotic stress 
(Ruas-Madiedo et al. 2010; Russell et al. 2011). 
Exposure to the stress conditions of the gastrointestinal tract may alter the 
metabolic, physiological and surface properties of potential probiotic 
microorganisms, thereby affecting the production of colonisation factors such 
as EPS, such that their ability to adhere to the intestinal epithelium is 
affected (Collado et al. 2006). Modification to adhesion properties may lead 
to alteration in probiotic capacity (Tuomola et al. 2001).  
The study of effects of gastrointestinal stresses on the ability of bifidobacteria 
and other potential probiotic microorganisms to adhere to the intestinal 
epithelium may be carried out by assessing biofilm formation, as well as 
production of EPS.  Therefore, this chapter was aimed at examining possible 
effects of exposure of bifidobacteria to stress conditions on their potential for 
in vitro biofilm formation and EPS production. 
138 
 
5.2 Materials and Methods 
5.2.1 Bacterial cultures 
Bifidobacterial cultures were namely Bifidobacterium breve NCTC 11815, B. 
longum NCTC 11818, B. animalis ssp. lactis strain C and B. animalis ssp. 
lactis strain D, as described in 2.2.1. 
  
5.2.2 Stress treatment 
The bifidobacteria (B. animalis ssp. lactis C and D, B. breve and B. longum) 
were exposed to acid, bile, osmotic and oxidative stress as described in 
3.2.2.1 – 3.2.2.4. Unstressed cells were prepared as described in 3.2.2.5. 
 
5.2.3 Crystal violet assay 
Biofilm formation was assessed by the crystal violet assay method described 
by Stepanovic et al. (2007), with modifications. Twenty µl of bacterial 
suspension was added to 180 µl of Reinforced Clostridial Medium (RCM) 
contained in flat-bottomed 96-well polystyrene microtitre plates (Sterilin Ltd 
UK) and incubated under anaerobic conditions at 37 °C for 48 hours. 
Negative control was 200 µl RCM. After incubation, the medium was 
removed and wells were washed three times with 200 µl of phosphate 
buffered saline (PBS, BR0014, Oxoid) to remove non-adherent and loosely 
adherent cells. After washing, the remaining adherent bacterial cells were 
heat-fixed by exposing to hot air at 60 °C for 1 hour. The fixed cells were 
stained with 150 µl of 1% crystal violet (Sigma) for 15 minutes at room 
temperature, after which, the wells were washed by placing under running 
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tap water until plates were free of the stain. The microtitre plates were air 
dried at room temperature and 200 µl of dimethyl sulfoxide (Sigma) was 
added to each well. Plates were incubated at room temperature for 1.5 hours 
to solubilise the crystal violet. One hundred µl of the resulting solutions were 
transferred into a fresh microtitre plate for optical density (OD) measurement 
(Fig. 5.1). The OD of each well was measured at 595 nm in an Omega 
Fluostar plate reader (BMG Labtech Ltd, UK). Experiments were done in 
three replicates and mean OD calculated. 
 
 
Fig. 5.1 96-well microtitre plate showing wells containing solubilised crystal violet for 
before measuring the optical density to assess biofilm formation 
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5.2.4 Expression of gtf01207 EPS-synthesis gene in B. animalis ssp. 
lactis (C) by quantitative reverse transcription polymerase chain 
reaction (qRT-PCR) 
Samples were prepared and qRT-PCR analysis was carried out as described 
in 4.2.5. The primers used to amplify the gtf01207 gene, which is involved in 
exopolysaccharide (EPS) synthesis, and reference genes atpD, tufA and ldh 
are listed in Table 5.1. The expression of the gene in B. animalis ssp. lactis 
only was studied because gtf01207 has only been associated with B. 
animalis ssp. lactis in previous literature, and the available primer sequences 
were therefore specific to it (Ruas-Madiedo et al. 2009). Due to time and cost, 
it was not feasible to check for suitable primers for B. breve and B. longum. 
The primers used for B. animalis ssp. lactis were as described in Ruas-
Madiedo et al. (2009) and supplied by Sigma-Aldrich, UK. For accurate gene 
quantification, the expression of the gene of interest, i.e. gtf01207, was 
normalised to the expression of the reference genes, whose expression does 
not change under the various experimental conditions. The reference genes 
were as used by Foroni et al. (2011). The stability of these reference genes 
was assessed using the geNorm software. Reference gene primers were 
designed by qStandard Ltd, UK. Quantitative PCR was carried out in three 
replicates, and mean number of normalised copies per reaction was 
calculated. 
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Table 5.1 Primer sequences 
Gene Forward primer Reverse primer 
gtf01207 5’-CGTGCTGAGTCGAAAGAATCG-3’ 5’-TTGTAGAACGTGATCGGCTCA-3’ 
atpD 5’-CTCCACCTCGCGAATCCT-3’ 5’-GAAGTTCTGGCCGAGGAAC-3’ 
tufA 5’-GAGTACGACTTCAACCAGATCG-3’ 5’-ATGTTCTTCACGAAGTCGGC-3’ 
ldh 5’-CCGACATGGTCGTCATCAC-3’ 5’-GGGTTGGTGATGAGCATGTA-3’ 
 
5.2.5 Statistical analysis 
Data were analysed by Student’s t-test to compare unstressed and stressed 
data groups, using Microsoft Excel 2007. Statistical significance was set at P 
≤ 0.05. 
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5.3 Results 
5.3.1 Quantitation of biofilm formation by crystal violet assay 
Biofilm formation in the tested bifidobacteria was quantified by the crystal 
violet assay. Effects of exposure to acid, bile, osmotic and oxidative stress 
on the potential for biofilm formation were also assessed. Comparisons of 
mean optical densities for the tested organisms exposed to stress were 
made, relative to the control. Optical densities represent the amount of 
released crystal violet, providing an estimation of the biofilm formation. 
There appeared to be low biofilm formation in all four strains tested, as the 
optical density values were generally rather low (<0.1). Among the 
unstressed bifidobacteria, the relative order of biofilm formation, from highest 
to lowest, was B. breve, B. animalis ssp. lactis (C), B. animalis ssp. lactis (D) 
and B. longum. The effects of exposure to acid, bile, osmotic and oxidative 
stresses on the the biofilm formation of these organisms are summarised in 
Table 5.2. 
 
Table 5.2 Effects of exposure to stress on biofilm formation relative to 
unstressed cultures   
 Acid Bile Osmotic Oxidative 
B. animalis ssp. lactis (C) 0 + + + 
B. animalis ssp. lactis (D) 0 + 0 + 
B. breve - - - - 
B. longum 0 - 0 0 
(+ = higher biofilm; 0 = no difference; - = lower biofilm) 
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Acid stress appeared to result in no significant difference in biofilm formation 
in both B. animalis ssp. lactis strains and B. longum, while there was a 
significantly less biofilm formation in B. breve (Fig. 5.2a).  
There appeared to be significant difference in all four bifidobacteria exposed 
to bile stress, with significantly higher biofilm formation observed in both B. 
animalis ssp. lactis strains and significantly lower biofilm formation observed 
in B. breve and B. longum (Fig. 5.2b).  
Osmotic stress appeared to have no significant effect on B. animalis ssp. 
lactis (D) and B. longum, while biofilm formation in B. animalis ssp. lactis (C) 
and B. breve appeared to be significantly higher and lower, respectively (Fig. 
5.2c).  
Significantly higher biofilm formation in oxidatively stressed cultures were 
observed in both B. animalis ssp. lactis strains, while there appeared to be 
significantly lower biofilm formation in B. breve and no significant difference 
in B. longum (Fig. 5.2d).  
 
 
 
 
144 
 
 
Fig. 5.2a Biofilm formation in bifidobacteria after exposure to acid stress. Error bars 
represent standard error of the mean (SEM). Significant differences are 
represented by asterisks (P ≤ 0.05) 
 
 
Fig. 5.2b Biofilm formation in bifidobacteria after exposure to bile stress. Error bars 
represent standard error of the mean (SEM). Significant differences are 
represented by asterisks (P ≤ 0.05) 
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Fig. 5.2c Biofilm formation in bifidobacteria after exposure to osmotic stress. Error 
bars represent standard error of the mean (SEM). Significant differences are 
represented by asterisks (P ≤ 0.05) 
 
 
Fig. 5.2d Biofilm formation in bifidobacteria after exposure to oxidative stress. Error 
bars represent standard error of the mean (SEM). Significant differences are 
represented by asterisks (P ≤ 0.05) 
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5.3.2 Expression of gtf01207 EPS-synthesis gene 
Expression of gtf01207, a gene involved in EPS synthesis, was measured in 
B. animalis ssp. lactis (C) exposed to acid, bile and osmotic stress, as well 
as unstressed, by qRT-PCR. B. There appeared to be higher expression of 
gtf01207 in B. animalis ssp. lactis (C) exposed to acid, bile and osmotic 
stress conditions, in comparison to the unstressed, with the osmotically 
stressed culture showing significantly higher expression than the unstressed 
(Fig. 5.3).  
 
 
Fig. 5.3 Expression of gtf01207 under control, acid, bile and osmotic conditions. 
Error bars represent standard error of the mean (SEM). Asterisks represent 
significant differences in comparison to the control (P ≤ 0.05) 
 
 
 
0
50000
100000
150000
200000
250000
300000
Control Acid Bile Osmotic
n
o
rm
al
is
e
d
 c
o
p
y 
n
o
./
rx
n
Treatment
*
147 
 
5.4 Discussion 
This present study was aimed at investigating the possible effect of exposure 
to stress on the ability of bifidobacteria to form biofilms. This was under the 
assumption that stress may lead to modifications in the cell surface, as 
suggested by previous studies. Ruiz et al. (2007) reported morphological 
changes, as studied by transmission electron microscopy (TEM) and 
changes in membrane protein: phospholipid ratio in B. animalis ssp. lactis in 
response to bile, though no indication was given about any possible effect on 
adhesion capability or biofilm formation. Ahn et al. (2001) also observed 
morphological changes, as studied by scanning electron microscopy (SEM) 
and changes in protein and fatty acid profiles of bifidobacteria under oxygen 
stress.  
Furthermore, the study by Guglielmetti et al. (2009) on the adhesion of B. 
bifidum MIMBb75 to human intestinal cell lines showed that adhesion was 
reduced by bile salts as well as low pH. It was suggested that this reduction 
in adhesion may be due to modifications in the cell surface properties. 
Lebeer et al. (2007) in their study of biofilm formation by Lactobacillus 
rhamnosus GG found that low concentrations of bile (0.05%, 0.1%, 0.2%) 
stimulated biofilm formation, though it reduced with increasing concentration, 
and was greatly reduced at higher concentrations (1.5%). Low pH was also 
found to significantly reduce biofilm formation in Lb. rhamnosus GG. It was 
also suggested that alterations in the cell surface by acid and bile may 
influence biofilm development.  
This present study differed from that of Lebeer et al. (2007) in that whereas 
Lebeer et al. assessed biofilm formation with the stress agent present in the 
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medium, this study assessed biofilm formation in normal medium, after 
exposing the organisms to the stress agent. This was done on the basis that 
probiotic microorganisms would be exposed to and have to survive stress in 
the upper part of the gut, before reaching the colon, which provides a 
favourable condition for their growth.   
The results of the biofilm study showed optical density values which could be 
considered as very low (<0.1). This could be due to culture medium used. 
Media composition has been shown to have a major influence on in vitro 
biofilm formation (Lebeer et al. 2007; Stepanovic et al. 2007). Reinforced 
Clostridial Medium (RCM) was used to culture the bifidobacteria in this study. 
It is a semi-solid medium, i.e. it contains some agar, which makes it suitable 
for cultivating obligately anaerobic bacteria like Bifidobacterium spp. It also 
contains L-cysteine (as cysteine hydrochloride), which is a reducing agent, 
lowering the redox potential to further encourage anaerobic conditions in the 
medium. The amino acid cysteine is also an important nitrogen source for 
bifidobacteria (Roy 2003).   
It could be suggested that while RCM is good for growth of bifidobacteria, it 
may not be suitable for in vitro biofilm formation. The presence of agar in the 
medium may have resulted in less adherence of the bacteria to the walls of 
the microtitre plates, and more adherence to the agar particles. It is not clear 
what the influence of other components of the medium may have had on 
biofilm formation. The presence of glucose as a carbon source in MRS 
medium was found to have a negative effect on biofilm formation by Lb. 
rhamnosus GG, though this effect was not observed in other Lb. rhamnosus 
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and Lb. casei strains studied (Lebeer et al. 2007). RCM also contains 
glucose (5g/L), but at a lower proportion to MRS (20g/L). 
Another possible explanation for the low biofilm formation could be the 
presence of a reducing agent in RCM. The study of Qian et al. (2011) on 
some Bifidobacterium spp. demonstrated that cells grown in MRS which is 
without cysteine, showed reduced intracellular granule and exopolymer 
production compared to those grown in MRS with cysteine and RCM. MRS-
grown cells also showed higher cell surface hydrophobicity; cell surface 
hydrophobicity has been positively correlated with adhesion ability to host 
cells (Perez et al. 1998; Pan et al. 2006). On the other hand, it may be due to 
the anaerobic incubation condition. Ninomiya et al. (2009), in their study of 
exopolysaccharide (EPS) production in a strain of B. longum, showed that a 
CO2 concentration of ≥20% in the anaerobic gas mixture was necessary for 
substantial EPS production. In this present study, the anaerobic gas mixture 
contained 10% CO2. This may have had an impact on the biofilm formation. 
The highest biofilm formation in the unstressed cultures was observed in B. 
breve, followed by both commercial B. animalis ssp. lactis strains, and then B. 
longum. Biofilm formation potential may be dependent on the bacterial strain, 
but also on the medium used. Therefore it is not clear if this order in biofilm 
formation would be the same, had another culture medium been used. 
Differences in biofilm formation between stressed and unstressed 
bifidobacteria were observed. In B. breve, there was lower biofilm formation 
in the cultures exposed to each of the four stresses studied. In both 
commercial B. animalis ssp. lactis strains, acid-stressed cultures showed no 
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difference in biofilm formation relative to the unstressed. Bile, osmotic and 
oxidatively stressed B. animalis ssp. lactis showed higher biofilm formation 
relative to the unstressed. B. breve, which produced the highest amount of 
biofilm in the unstressed state, appeared to be negatively affected by 
exposure to stress, whereas both commercial B. animalis ssp. lactis strains 
produced less biofilm in the unstressed state and appeared to be positively 
affected by exposure to stress. B. longum showed the least potential for 
biofilm formation, and was largely unaffected by exposure to stress.  
It may be suggested that biofilm formation in B. animalis ssp. lactis can be 
stimulated by exposure to stresses, and that biofilm formation in the B. breve 
strain studied can be suppressed by exposure to stresses. However, there is 
no clear explanation for how these changes in biofilm potential might occur, 
as well as how exposure to the individual stresses affects biofilm formation. It 
is possible that the effects of stress on the lag phase of bacterial cells (i.e. 
extended lag phases) may have an implication on the capacity to form 
biofilms (Kroukamp et al. 2010). This may provide an explanation for the B. 
breve observations, i.e. exposure of B. breve to stresses causes injury, 
which results in an extended lag to allow repair, and which ultimately affects 
biofilm formation. On this basis, it could be implied that B. animalis ssp. lactis 
is more resistant to stress, such that its lag phase is not highly affected by 
exposure to stress. 
Exopolysaccharide (EPS) production may be related to biofilm formation 
potential in bifidobacteria. As such, effects of stress on biofilm production 
may be linked to effects of stress on EPS production. Bifidobacterium spp. 
have been screened for EPS production and EPS has been quantified and 
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characterised (Ruas-Madiedo et al. 2007; Audy et al. 2010; Leivers et al. 
2011; Fanning et al. 2012; Lopez et al. 2012; Prasanna et al. 2012).  
In this study, EPS production was not quantified. However, the expression of 
gtf01207, an EPS-synthesis gene in B. animalis ssp. lactis, was studied after 
exposure to stress conditions. Ruas-Madiedo et al. (2009) observed 
enhanced production of EPS by B. animalis ssp. lactis in the presence of bile, 
as studied by cryo-SEM, as well as increased expression of gtf01207, a gene 
which codes for a priming glycosyltransferase (p-GTF) involved in EPS 
synthesis. The p-GTF catalyses the transfer of a sugar-1-phosphate to a 
lipophilic carrier molecule anchored in the cell membrane, which is the first 
step in the assembly of the repeating unit which builds the polysaccharide 
(Ruas-Madiedo et al. 2007).  
This present study showed higher expression of gtf01207 in B. animalis ssp. 
lactis after exposure to acid, bile and osmotic stresses, though only 
significantly for osmotic stress. There was also some correlation between the 
biofilm results and the EPS gene expression results. This may suggest that 
EPS production is stimulated by multiple stresses as a protective response, 
which also can enhance biofilm formation.  
This suggestion may be justified by the study of Vieira et al. (2004) on the 
bolA gene in Escherichia coli. The bolA gene, which is a stress response 
gene that causes round morphology when over-expressed, was found to be 
involved in biofilm development. Over-expression of the gene induced biofilm 
development, while deletion of the gene decreased biofilm formation. Under 
stress conditions, bolA was expressed, and consequently biofilm formation 
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induced. This observation led to the suggestion that biofilm is a protective 
mechanism against harsh environmental conditions.    
These modifications which occur in the presence of stress may be stress 
tolerance or response mechanisms, which in turn, impact, positively or 
negatively, on the adhesion and colonisation potential of bifidobacteria and 
other probiotics. It may be suggested that bifidobacteria which can show 
increased or higher biofilm formation and EPS production in response to 
stress would be good candidates for probiotic use, as demonstrated by B. 
animalis ssp. lactis in this study. For instance, Collado et al. (2006) observed 
that acid-resistant strains of bifidobacteria showed great adhesion and 
pathogen displacement capacity. Similarly, Candela et al. (2010) reported 
that stress-related proteins such as DnaK and enolase, which are suggested 
to play roles in the binding of B. animalis ssp. lactis to human epithelial cells, 
were induced in response to bile. 
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5.5 Conclusion 
Adhesion and colonisation of the intestine is important for any probiotic effect 
to be seen. As such, in light of the fact that probiotics are exposed to various 
stress conditions before reaching the large intestine, it may be advisable to 
assess the in vitro biofilm formation and EPS production of candidate 
probiotics after exposure to stress. This may be more representative of the 
situation in vivo, and may reveal new candidate probiotic strains. Culture 
media and culture conditions may need to be considered carefully when 
studying biofilm formation in bifidobacteria. The higher biofilm formation and 
gtf01207 expression shown by B. animalis ssp. lactis after exposure to stress, 
in this study, may be used to justify its use as a potential probiotic.  
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CHAPTER SIX: GENERAL DISCUSSION 
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6.1 Scope of research 
The aim of this study was to examine whether bifidobacteria, and by 
extension, other potentially probiotic microorganisms, can exhibit changes in 
their desired in vitro probiotic functional properties when exposed to stress 
conditions similar to those they can be exposed to during food production, 
and particularly during gut transit. This was based on the hypothesis that 
since various changes occur in bacterial cells in response to environmental 
stress, perhaps there would be an impact on the functional properties of 
probiotic microorganisms as a result. Another hypothesis this study 
attempted to test was that perhaps stress response mechanisms did not only 
aid survival and viability of probiotic microorganisms, but that they were also 
integral to the beneficial properties of probiotic microorganisms.  
The idea was that if potentially probiotic microorganisms were exposed to 
stress before assessing their functional properties, the outcomes of such 
assessment would give a more realistic insight into the an organism’s actual 
potential to provide health benefit. The research was also a means of further 
understanding the mechanisms of probiotic action, by particularly studying 
the interaction between stress and functionality.  
 
6.2 Selection of stress conditions 
The effects of acid, bile, osmotic and oxidative stresses on antimicrobial 
activity, antibiotic susceptibility and biofilm formation, were examined. The 
particular conditions used for each stressor were selected on the basis of 
identifying conditions which resulted in no growth after 24 hours of exposure, 
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thus indicative of stress, but which also resulted in negligible reduction in cell 
numbers after one hour of exposure (see Chapter 2). This was important 
because comparisons were being made with unstressed controls, and it was 
necessary to ensure that any differences observed were as a result of effects 
of stress on the bacterial cells, rather than on the bacterial cell numbers.  
One hour exposure was considered as sufficient exposure time, as this was 
demonstrated by Zomer et al. (2009) and Zomer and van Sinderen (2010), 
where one hour exposure of B. breve UCC2003 to various stresses revealed 
changes in the regulation of various genes in response to the stresses. Also, 
as gut transit time can range from <1 – 4 hours (Li et al. 2010), one hour 
exposure was considered appropriate to represent exposure to conditions in 
the gut.     
Among the stress conditions chosen, more extreme conditions were 
generally used to elicit stress in the commercial B. animalis ssp. lactis strains, 
in comparison to those used to elicit stress in B. breve and B. longum, which 
are bifidobacteria of human origin. This further demonstrated the reported 
greater stress tolerance shown by B. animalis ssp. lactis, which makes it 
favoured commercially, among other bifidobacteria (Raeisi et al. 2013).  
 
6.3 Effects of stress on probiotic functionality 
Potential probiotic microorganisms are required to meet various functional 
criteria, which are usually determined in vitro. These properties have a basis 
in the proposed mechanisms of probiotic action (see Chapter 1). This study 
assessed the effects of stress on antimicrobial activity, antibiotic 
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susceptibility and biofilm formation, as described in Chapters 3, 4 and 5, 
respectively.  
The antimicrobial activities of bifidobacteria exposed to each of the stresses 
were maintained, although there appeared to be lower antimicrobial activity, 
on the basis of smaller inhibition zones observed, relative to the unstressed 
bifidobacteria. This can suggest that stressed bifidobacteria released less 
inhibitory substances, mainly organic acids, into the surrounding medium, 
thereby resulting in less inhibition of the indicator bacteria. The explanation 
for this may be that stress affects the lag phase, extending it, such that by 
the time the experiments were stopped, there were less inhibitory 
substances released. Another possible explanation, which cannot however 
be supported by the methods used in this study, may be the impact of stress 
on the transcriptome of the bifidobacteria.  
An over-expression of genes involved in carbohydrate metabolism was 
observed in B. longum NCIMB 8809 exposed to bile. There was also an 
enhanced formation of lactic acid and acetic acid, and a decrease in the 
acetate/lactate ratio, suggesting more lactic acid was produced than usual 
(Sanchez et al. 2005). It can therefore be suggested that the lower 
antimicrobial activity observed in this study could be the result of altered 
sugar metabolism, leading to higher lactic acid production, and lactic acid is 
less inhibitory than acetic acid. Changes in the regulation of genes involved 
in carbohydrate metabolism were also observed after the exposure of B. 
breve UCC2003 to stress conditions (Zomer et al. 2009). 
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Antibiotic susceptibility patterns of bifidobacteria in this study remained 
generally unaffected by exposure to stress. Higher expression of the 
tetracycline resistance gene tet(W) was observed in B. animalis ssp. lactis (C) 
exposed to stress, although this did not correlate to higher MIC of 
tetracycline against  B. animalis ssp. lactis (C). These results may imply that 
exposure to stress does not affect the ability of probiotics to tolerate 
therapeutic doses of antibiotics, since the bifidobacteria in this study did not 
become more sensitive to the antibiotics tested after exposure to stress.  
The results of the biofilm formation study suggested that the effect of stress 
on biofilm formation may depend on the species of bifidobacteria, whereby 
some showed enhanced biofilm formation and others showed reduced 
biofilm formation. On this basis, a distinction could be made between 
commercial strains of bifidobacteria (B. animalis ssp. lactis strains C and D) 
and non-commercial strains (B. breve NCTC 11815 and B. longum NCTC 
11818). However it was not clear whether the lower biofilm formation 
observed in the non-commercial bifidobacteria was as a result of the effect of 
stress on the lag phase or on genes involved in biofilm formation, since B. 
animalis ssp. lactis is more resistant to stress. Higher expression of the EPS-
synthesis gene gtf01207 in B. animalis ssp. lactis (C) exposed to stress, 
particularly osmotic stress, may allude to a link between stress and biofilm 
formation, whereby stress is necessary to facilitate this property, and hence 
probiotic benefit. Overall, based on the results of individual experiments, it is 
not clear if there may be an effect of stress on functionality in vivo.  
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6.4 Implications of the study 
There has been recent controversy over the European Food Safety Authority 
(EFSA) health claims regulation, which rejected numerous health claims for 
probiotics, and the effective ban on the descriptive usage of the term 
‘probiotic’ as it implies health benefit. The reason for this has been the 
unsatisfactory dossiers of evidence available to back such health claims 
(Katan 2012; Salminen and van Loveren 2012; Binnendijk and Rijkers 2013).  
Various questions have been raised about whether the bacteria in probiotic 
products actually remain viable and whether they actually provide any benefit. 
A lot of research has gone into devising ways of shielding the bacteria from 
adverse environmental conditions, such as microencapsulation and delivery 
through tablets and other formulations (Champagne et al. 2005; Ross et al. 
2005). To some extent, this study has attempted to shed light on what could 
happen to probiotic bacteria which are not protected, and possibly contribute 
to the case for delivering probiotics through such protective means. On the 
other hand, some results, i.e. biofilm formation in B. animalis ssp. lactis, may 
facilitate the suggestion that some probiotic bacteria need to be exposed to 
stress for their functional properties to be enhanced, and that stress-
tolerance is not only for the purpose of ensuring survival and viability, but 
also for beneficial properties. This would however need to be further 
explored. 
Another possible consequence from this study may be the inclusion of a 
stress step, where candidate probiotic microorganisms are exposed to 
relevant shocks before a functional property is assessed, in a bid to better 
represent what can happen in reality. This might even reveal candidates that 
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would have been previously unlikely, or conversely, discount some 
established candidates. From the results of this study, it could be suggested 
that B. animalis ssp. lactis is justified in its use as a probiotic, while the B. 
breve and B. longum strains used in this study would need to be protected 
from stress in order to increase the likelihood of obtaining benefit from their 
antimicrobial and biofilm formation properties. 
 
6.5 Limitations of the study 
Most of the investigations in this study involved transferring the stress-
exposed cultures into fresh media. Whilst consistency was maintained, and 
there was comparison with an unstressed control, it can be argued whether 
the stressed cultures were truly stressed, considering that they could have 
undergone repair of any injury caused by the stresses they were exposed to, 
such that it would be difficult to observe any clear differences in the 
properties being studied. Furthermore, any differences may have been as a 
result of extension of the lag phase to allow repair of injury. Therefore, it may 
be more appropriate to study the cells directly, rather than by means 
involving culture media. 
The study of gene and protein expression may be suitable in this regard. 
However, in this study, only two genes were studied. In reality, several genes 
may be responsible for potential probiotic microorganisms to exhibit certain 
functional properties. Thus, it may be better to explore the relationship of 
various genes and proteins to certain functional properties, and how changes 
in their expression due to stress affect the associated functional properties.  
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However, the experimental design may be justified on the basis that it better 
represents the scenario in vivo, whereby the probiotics would have to first go 
through stressful conditions, before finally reaching the large intestine, which 
is their site of action, and which is a suitable environment of their growth. 
Further to this, it may have been appropriate to additionally study the gene 
expression in bacteria which had recovered after exposure to short-term or 
prolonged stress. This may have given an indication of whether the changes 
in the expression of certain genes related to a functional property persist 
when the stress is no longer there. This could also have been applied to the 
methods used for assessing the functional properties, i.e. functional 
properties should have been assessed after clear recovery from the stress, 
such that it would demonstrate whether exposure to stress can result in 
changes in heritable phenotypes. 
In this regard, the concept of epigenetics, which studies modifications to 
DNA, which do not involve DNA mutation (Kasuga and Gijzen 2013), could 
be explored. It could be suggested that the exposure of the bifidobacteria to 
stress may result in epigenetic changes which are passed on to the next 
generation. However the design of this study was not able to support the 
investigation of this theory. 
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CHAPTER SEVEN: CONCLUSION AND SUGGESTIONS FOR 
FUTURE WORK 
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This study comparatively assessed some functional properties of commercial 
and non-commercial bifidobacteria which were exposed to stress conditions 
and unstressed. The aim was to evaluate whether the functional properties of 
probiotic microorganisms, which can be indicators of the potential to provide 
health benefit, are affected positively or negatively, when exposed to stress 
conditions. This study was considered necessary because of the gaps in 
knowledge about the exact mechanisms by which probiotics can exert their 
health benefits. Studying the effects of stress on in vitro functional properties 
was considered as a means of understanding what may pertain in reality.  
Candidate probiotic microorganisms are assessed in a ‘native’ state, for their 
ability to tolerate stressful conditions of the gut, and also for other properties 
that suggest they would be beneficial, such as production of antimicrobial 
substances. However, there have been no studies on bifidobacteria to 
demonstrate that their probiotic beneficial properties are not changed after 
exposure to inevitable stress conditions. Therefore, in this study, the 
microorganisms were exposed short-term to individual stress conditions and 
then assessed for their functional properties. 
The study of antimicrobial activity suggested that the main effect of stress is 
on the growth rate of bifidobacteria, which may affect the amount of inhibitory 
substances present, although this is only relevant with the time at which the 
measurement is carried out. Antimicrobial activity was not lost as a result of 
exposure to stress. However it is not clear what implications a slower growth 
rate (extended lag phase) may have for actual probiotic benefit in a real 
sense. 
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The study of antibiotic susceptibility revealed no clear effect of stress, 
suggesting that probiotic microorganisms are neither more sensitive nor 
more resistant to antibiotics because of stress. An absence of increased 
sensitivity implies that they can be co-administered with antibiotics, and that 
their potential to provide probiotic benefit is not diminished. 
The study of biofilm formation showed that stress may stimulate biofilm 
formation, but in a strain or species-dependent manner. The apparent 
stimulation of biofilm formation by stress in the commercial strains could 
possibly justify the prevalence of certain probiotic strains over others. It could 
imply that some beneficial properties require exposure to stress in order to 
be exhibited. This idea may be crucial to the understanding of how probiotics 
work.  
To better understand the relationship between stress response and other 
probiotic functional properties, a molecular approach would be better placed 
to study this. Genes and proteins which could act as biomarkers for certain 
functional properties would need to be identified, and changes in their 
expression under different stress conditions would be useful as an indicator 
of the influence of stress on functionality. 
In addition, whilst this research looked at stress conditions individually, future 
work could study the probiotic microorganisms after exposure to consecutive 
stresses or combinations of stress conditions. This may be more 
representative of what could occur in reality, and may also reveal differences 
because of exposure to a previous stress. 
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Further to this, the study of the impact of conditions encountered during 
processing and propagation of probiotic cultures may be helpful to 
understand if technological stress conditions have a role in strain differences 
and also on the relationship between subsequent gastrointestinal stress and 
beneficial functional properties.  
The study documented here was focused on some members of 
Bifidobacterium spp. Future studies could see an expansion to other 
bifidobacteria, as well as other probiotic groups such as Lactobacillus spp., 
Lactococcus spp., etc. More in vitro functional properties could be studied as 
well, and the studies of gastrointestinal stress could be carried out by using 
in vitro gut models in order to give an even more realistic representation of 
how gastrointestinal stress could affect functional properties. The influence of 
the food matrix and cold storage on probiotic functional properties could also 
be studied. Functional properties could be studied at different lengths of 
storage in the food carrier, using a molecular approach to assess whether 
certain genes are induced or repressed by components of the food products, 
and if this has any impact on functional properties, and in particular, after 
subsequent exposure to gastrointestinal stress. Furthermore, it could be 
useful to study the impact of host factors and other gut microbiota on the 
functional properties of probiotic microorganisms. These studies could 
contribute to the understanding of probiotic functionality and the interaction 
between these properties and different conditions encountered by probiotics. 
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APPENDIX 
Media and composition 
Reinforced Clostridial Medium (RCM, CM0149, Oxoid Ltd) g/l 
Yeast extract 3 
‘Lab-Lemco’ powder 10 
Peptone 10 
Glucose 5 
Soluble starch 1 
Sodium chloride 5 
Sodium acetate 3 
Cysteine hydrochloride 0.5 
Agar 0.5 
 
Reinforced Clostridial Agar (RCA, CM0151, Oxoid Ltd) g/l 
Yeast extract 3 
‘Lab-Lemco’ powder 10 
Peptone 10 
Glucose 5 
Soluble starch 1 
Sodium chloride 5 
Sodium acetate 3 
Cysteine hydrochloride 0.5 
Agar 15 
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De Man, Rogosa, Sharpe Broth (MRS, CM0359, Oxoid Ltd) g/l 
Peptone 10 
‘Lab-Lemco’ powder 8 
Yeast extract 4 
Glucose 20 
Tween 80 1 
Dipotassium hydrogen phosphate 2 
Sodium acetate 3H2O 5 
Triammonium citrate 2 
Magnesium sulphate 7H2O 0.2 
Manganese sulphate 4H2O 0.05 
 
Tryptone Soya Broth (TSB, CM0129, Oxoid Ltd) g/l 
Pancreatic digest of casein 17 
Enzymatic digest of soya bean 3 
Sodium chloride 5 
Dipotassium hydrogen phosphate 2.5 
Glucose 2.5 
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Nutrient Agar (NA, CM0003, Oxoid Ltd) g/l 
‘Lab-Lemco’ powder 1 
Yeast extract 2 
Peptone 5 
Sodium chloride 5 
Agar 15 
 
Violet Red Bile Glucose Agar (VRBG, CM1082, Oxoid Ltd) g/l 
Enzymatic digest of animal tissues 7 
Yeast extract 3 
Bile salts No. 3 1.5 
Sodium chloride 5 
Neutral red 0.03 
Crystal violet 0.002 
Glucose 10 
Agar 12 
 
Phosphate Buffered Saline (PBS, BR0014, Oxoid Ltd) g/l 
Sodium chloride 8 
Potassium chloride 0.2 
Disodium hydrogen phosphate 1.15 
Potassium dihydrogen phoshate 0.2 
 
